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Introduction {#sec1}
============

The vast majority of mitochondrial membrane proteins are synthesized on cytosolic ribosomes and subsequently imported into the organelle by the translocase of the outer membrane (TOM) ([@bib19], [@bib47], [@bib78]). Mitochondrial β-barrel and metabolite carrier precursor proteins with multiple transmembrane segments are sorted through the intermembrane space (IMS) to get engaged with their dedicated membrane integration machineries. β-barrel membrane proteins are inserted by the sorting and assembly machinery at the outer membrane (SAM/TOB) ([@bib49], [@bib79]) and metabolite carrier proteins by the carrier translocase of the inner membrane (TIM22) in a manner that is dependent on the potential (Δψ) across the inner membrane ([@bib32], [@bib53], [@bib62]). The mitochondrial IMS contains a single chaperone system comprising the small Tim proteins, Tim8, Tim9, Tim10, Tim12, and Tim13 ([@bib34], [@bib63], [@bib71]). The TIM chaperone system is crucial to mediate the transfer of some of the most abundant mitochondrial membrane protein precursors from the TOM complex to either SAM or the TIM22 complexes ([@bib46]). The mitochondrial IMS assembly machinery MIA covalently links the twin CX~3~C cysteine motif of the TIM chaperone proteins by introducing disulfide bonds, such that both N- and C-terminal α-helical segments form a cleft ([@bib12], [@bib44]).

High-resolution structures show that the soluble TIM chaperone complexes assemble as alternating circular hexamers formed by three subunits of each Tim9 and Tim10, or Tim8 and Tim13 for the TIM9·10 and TIM8·13 chaperones, respectively ([@bib5], [@bib77]). The TIM22 complex contains an additional translocase-bound form composed of the three essential TIM chaperone proteins Tim9, Tim10, and Tim12, which constitute a specific complex for the insertion of inner membrane precursors ([@bib34], [@bib42], [@bib63]). In contrast, the soluble TIM8·13 complex is considered to be redundant to the TIM9·10 complex in the intermembrane space ([@bib23], [@bib27], [@bib80]). Nonetheless, mutations affecting the human Tim8 homolog DDP1 are associated with the mitochondrial neuronopathy called Mohr-Tranebjærg or deafness dystonia syndrome ([@bib35]).

It is currently unknown how the TIM chaperones bind various membrane protein precursors and manage their transfer to their corresponding target membrane, also leaving the molecular basis of this chaperone-related disease unclear. Four major models for TIM chaperone function have been proposed ([@bib5], [@bib43], [@bib70], [@bib77]): (1) binding of the substrate in the central cavity formed by the tentacle-like inner N termini, similar to the structurally unrelated chaperone prefoldin in the cytosol and Skp in the bacterial periplasm; (2) intercalation of a metabolite carrier helix-loop-helix motif in opposing orientation to a Tim chaperone monomer, referred to as "bisecting dimerization"; (3) incorporation of hydrophobic substrate helices into the TIM chaperone ring structure by competitive Tim subunit displacement; and (4) natively folded substrate wedged within the N-terminal tentacles. However, complexes of TIM chaperones with the aggregation-prone membrane proteins in transit have remained elusive, due to the challenge of preparing and characterizing such complexes *in vitro* and the difficulty of obtaining structural insights into chaperone/client protein complexes. The structure, dynamics, and interactions of this complex remain unresolved.

Results {#sec2}
=======

Nuclear Magnetic Resonance Reveals the Binding of Precursor Proteins to the Mitochondrial TIM Chaperones {#sec2.1}
--------------------------------------------------------------------------------------------------------

To gain structural insight into the chaperone mechanism, we developed *in vitro* protocols to reconstitute recombinantly expressed carriers with the TIM9·10 chaperone. Samples for structural studies were prepared by attaching unfolded carriers to a metal-affinity resin, addition of TIM9·10 and elution of the chaperone/precursor protein complex ([Figure 1](#fig1){ref-type="fig"}A). In an orthogonal approach, we produced the GDP/GTP carrier Ggc1/TIM9·10 complex by *in vitro* translation ([Figure S1](#figs1){ref-type="fig"}A). These findings establish that recombinant TIM9·10 is able to bind the precursor proteins in an unfolded form as well as polypeptide exiting the ribosome. Nuclear magnetic resonance (NMR) spectra of TIM9·10 carrying either Ggc1 or Aac3 (ADP/ATP carrier, or adenine nucleotide translocator) feature cross-peak positions that are similar to those of apo TIM9·10 ([Figures 1](#fig1){ref-type="fig"}B and [S1](#figs1){ref-type="fig"}B--S1D). The similarity of apo and holo complex spectra establishes that the hexameric chaperone remains structurally intact upon membrane protein binding, excluding models in which either monomeric Tim chains bind to precursor proteins or in which α helices of the carrier precursor protein intercalate in between the subunits of the oligomeric chaperone ([@bib77]). Interestingly, only a single set of cross-peaks is observed, indicating that each of the symmetry-related Tim subunits in the hexameric complex adopts the same conformation and precursor interaction on the fast-exchange NMR timescale (i.e., up to the ms \[ms\] timescale). Local asymmetry is averaged out on the sub-ms timescale. The resonance peak intensities in samples of TIM9·10 bound to carrier proteins are reduced compared to apo TIM9·10, in particular for backbone NH sites ([Figures S1](#figs1){ref-type="fig"}E--S1G). As outlined below, the strongly reduced NMR peak intensity can be ascribed to the larger size and conformational dynamics of the TIM/precursor protein complexes.Figure 1Inner Membrane Precursor Proteins Bind in a Hydrophobic Cleft of TIM9·10(A) *In vitro* formation of the TIM9·10/Ggc1 complex by a Ni-NTA based pull-down approach, monitored by SDS-PAGE analysis and Coomassie staining. FT, flow-through; E, TIM9·10/Ggc1 fraction eluted from the column with imidazole; LC, loading control (subsequent imidazole-elution with guanidine hydrochloride of Ggc1 not bound by TIM9·10).(B) Methyl ^1^H-^13^C HMQC NMR spectra of apo and Ggc1-bound ALV-labeled TIM9·10.(C) Transferred NOE effects from protonated Ggc1 to deuterated, ALV-labeled TIM9·10 as a function of the TIM9·10 methyl residue number. The resonance of V16 (purple, dashed) is broadened beyond detection upon Ggc1 binding. Error bars were determined from the spectral noise level and error propagation (see [STAR Methods](#sec4){ref-type="sec"}).(D) Structural view of the transferred NOE data from (C).See also [Figure S1](#figs1){ref-type="fig"}.Figure S1Formation and Characterization of TIM9·10 Binding Mitochondrial Carriers, Related to [Figure 1](#fig1){ref-type="fig"}(A) Production of TIM9·10/Ggc1 using a cell-free protein production reaction mixture containing the expression plasmid encoding the Ggc1 sequence, complemented by either detergent (Brij35) or different concentrations of TIM9·10. The latter was expressed in *E. coli* and purified using standard procedures described in the Methods section. The amount of His-tagged Ggc1 in solution or in the insoluble pellet was analyzed by SDS-PAGE and immunodecoration with anti-His antibody. In the presence of detergent (without TIM9·10), Ggc1 is found exclusively in the soluble fraction (lane 8). In the absence of detergent and chaperone (lanes 2 and 9), Ggc1 is found only in the pellet, as expected for a highly aggregation-prone polypeptide. With increasing amounts of TIM9·10 (lanes 10-13) the amount of Ggc1 in solution increases, while the amount in the pellet decreases (lanes 3-6). This data shows that recombinantly expressed TIM9·10 is functional and allows retaining Ggc1 in solution in a concentration-dependent manner.(B-D) Relative peak intensities of NMR signals of TIM9·10 in complex with Ggc1 (orange), Aac3 (red) or Aac3(2TM) (purple).(E-G) Backbone HN and ALV methyl spectra of TIM9·10 in apo and holo complexes, corresponding to the data shown in B -- D. Precursor protein binding leads only to small changes of peak positions, but leads to strong reduction of the peak intensities. Note that numerous backbone NH sites are broadened beyond detection, in particular in the hydrophobic cleft. The higher peak intensities in the TIM9·10/Aac3(2TM) sample, compared to full-length Aac3 and Ggc1, is ascribed to the fact that Aac3(2TM) recruits only one TIM9·10 hexamer, thus resulting in a smaller complex.(H and I) Paramagnetic relaxation enhancement (PRE, proton-ΔR~1~) effects at ALV methyl sites on TIM9·10 induced by two different paramagnetically-tagged Ggc1 precursor proteins bound to TIM9·10, where the MTSL spin label is attached to either C222 or C8 of Ggc1. ΔR~1~ is obtained as the difference of R~1~ measured with bound MTSL-labeled Ggc1, and the corresponding relaxation rate constant in the same sample after reduction of the spin label by addition of ascorbic acid. The resonance of Val16 is broadened beyond detection (indicated in purple). In the dataset shown in (I), residue L36 is not graphically shown due to its large error margin; its value is 0.097 ± 0.5. All error margins shown in this figure were determined from 3 times the spectral noise level.(J and K) The observed PRE effects are plotted onto the structure of TIM9·10 in (MTSL at C222 in J) and (MTSL label at C8 in K).

For further structural investigations, we exploited the intrinsically higher detection sensitivity of methyl groups and used deuterated samples with ^13^CH~3~-labeling at Ala, Leu, and Val (ALV) side chains. We identified the binding sites of the precursor protein on the TIM hexamer through NMR saturation-transfer methods, which probe the spatial proximity of hydrogen atoms on Ggc1 to ALV methyl groups on TIM9·10 ([Figures 1](#fig1){ref-type="fig"}C and 1D). Residues with the strongest transferred-nuclear Overhauser effects (NOE) are located in the cleft formed between the N- and C-terminal helices. To obtain independent insight into the precursor protein binding, we used paramagnetic NMR experiments in which we attached a paramagnetic spin label to Ggc1, either in a transmembrane helix (residue 222) or at the N terminus (residue 8), and monitored how the Ggc1-bound spin label enhances the spin relaxation of ALV sites on TIM9·10. In agreement with the saturation-transfer data, the largest PRE-effects are observed for residues located in the hydrophobic cleft ([Figures S1](#figs1){ref-type="fig"}H--S1K).

We then investigated whether precursors of outer-membrane β-barrel proteins use the same interaction cleft of TIM9·10. The methods, which were successfully used for generating complexes with inner-membrane precursor proteins, failed to yield stable complexes with full-length β-barrel precursors, suggesting that these complexes are less stable. However, we succeeded in analyzing the binding of a peptide fragment of the voltage-dependent anion channel (VDAC) comprising the two C-terminal β strands, VDAC~257--279~, to TIM9·10. Both cross-linking ([Figure 2](#fig2){ref-type="fig"}A) and NMR titration experiments ([Figures 2](#fig2){ref-type="fig"}B and 2C) demonstrated that only the cyclic VDAC~257--279~ peptide that adopts a β-hairpin conformation ([@bib31]) interacts with the chaperone while the linear variant does not ([Figures 2](#fig2){ref-type="fig"} and [S2](#figs2){ref-type="fig"}). This observation highlights the importance of the β-hairpin conformation for interaction. The binding site, revealed by backbone and methyl chemical-shift perturbations, comprises the same clamp-like binding cleft that interacts with inner-membrane protein precursors ([Figure 2](#fig2){ref-type="fig"}D).Figure 2β-Hairpin Formation Is Important for Binding of Outer Membrane Precursor Fragments(A) Crosslinking of Bpa-containing linear or cyclic β-hairpin peptides (VDAC~257--279~) at variable concentration (indicated at the top) with the TIM9·10 complex (5 μM) detected by SDS-PAGE and silver staining.(B) NMR chemical-shift perturbation (CSP) in wild-typeTIM9·10 upon titration with VDAC peptides. Shown is the sum of the CSPs of V16, L28, L31, V32, V70, and V74.(C) Residue-wise CSPs in wild-type TIM9·10 upon titration with cyclic VDAC~257--279~.(D) Structural view of the cyclic-VDAC~257--279~-induced CSPs.See also [Figure S2](#figs2){ref-type="fig"}.Figure S2Binding of VDAC~257-279~ Peptides to Wild-Type and Mutant TIM9·10, Related to [Figure 2](#fig2){ref-type="fig"}The protein constructs, (WT, or mutations V29K or F33Q of the Tim10 subunits) are indicated, as well as the identity of the peptide (linear, cyclic). Titration points with different concentrations of VDAC~257-279~ peptides (at a constant TIM9·10 concentration of 200 μM) are shown with different colors.

Single Point Mutations in the Conserved Binding Cleft of the TIM Chaperones Impair Cell Growth and Cause Lethality {#sec2.2}
------------------------------------------------------------------------------------------------------------------

To investigate the relevance of the identified binding cleft for TIM function, we performed a sequence alignment of mitochondrial TIM chaperone proteins from yeast to human. We found that residues in this binding cleft form a conserved core motif with hydrophobic residues located at positions −14, −11, −8, and −7 before and at +5, +11, and +15 after the twin CX~3~C motif ([Figures 3](#fig3){ref-type="fig"}A and [S3](#figs3){ref-type="fig"}A). The conserved hydrophobic positions point into the cleft between the N-terminal inner helix and the C-terminal outer helix ([Figure 3](#fig3){ref-type="fig"}B), which were identified by our structural NMR data as precursor binding sites. To evaluate the importance of the conserved motif *in vivo*, we performed site directed mutagenesis of the essential yeast *TIM9* and *TIM10* genes ([@bib68]). For all conserved positions in yeast Tim9 and Tim10, except for the positions −4 and +4 that form the cleft constriction ([Figure S3](#figs3){ref-type="fig"}B), the hydrophobic residues were replaced by hydrophilic amino acids. Growth of the resulting yeast *tim9* and *tim10* mutant strains was analyzed on fermentable glucose (YPD) and non-fermentable glycerol (YPG) medium ([Figures 3](#fig3){ref-type="fig"}C and [S3](#figs3){ref-type="fig"}C). The *TIM9* mutations M21S, V70K, and F74K are lethal and the mutations F24K, L27K, and Y28Q caused significant growth defects. The *TIM10* mutations L26K, V29K, M32K, F33Q, V76K, and M80K caused similar defects on both carbon sources, in agreement with the essential role of the TIM chaperones. To analyze the *in vivo* defects of these single point mutations, mitochondria were isolated by differential centrifugation from cells grown at non-permissive condition at 37°C ([Figures 3](#fig3){ref-type="fig"}C and [S3](#figs3){ref-type="fig"}C). The steady-state levels, as monitored by western blotting, of inner membrane metabolite carriers like Aac2, Dic1 (dicarboxylate carrier), and Yhm2 (citrate and oxoglutarate carrier), as well as those of the carrier-like proteins Tim22 and Tim23, were reduced in the single point mutants affecting the hydrophobic motif of either Tim9 or Tim10 ([Figure 3](#fig3){ref-type="fig"}D). This mutational analysis substantiates the relevance of the conserved TIM chaperone motif for the biogenesis of metabolite carrier proteins.Figure 3Point Mutations Affecting the Conserved TIM Chaperone Motif Cause Growth Defects and Lethality(A) The bar graph shows the mean hydrophobicity of a TIM chaperone alignment highlighting a conserved motif (red). Sc, *Saccharomyces cerevisiae*; Dm, *Drosophila melanogaste*r; Hs, *Homo sapiens*.(B) Hydrophobic TIM chaperone motif plotted on the TIM9·10 structure.(C) Growth phenotype of *tim9* and *tim10* with single point mutants affecting the conserved motif. +, no growth defect; -- (red), (strong) growth defect; black, no growth; †, lethal.(D) Protein steady-state amounts of *tim9* and *tim10* mutant mitochondria subjected to SDS-PAGE followed by immunodecoration with indicated antibodies. OM, outer mitochondrial membrane; IMS, intermembrane space; IM, inner mitochondrial membrane.(E) Growth phenotype of *tim9* and *tim10* mutants in *tim8tim13*ΔΔ background as described in (C).(F) Yeast growth of *tim9* and *tim10* on fermentative (YPD) or non-fermentative (YPG) medium at 30°C.(G) Gel filtration profiles of hexameric TIM9·10 and *tim10* mutant complexes.See also [Figure S3](#figs3){ref-type="fig"}.Figure S3Characterization of Yeast Cells Expressing *tim9* and *tim10* Variants of the Conserved Motif, Related to [Figures 3](#fig3){ref-type="fig"}A, 3C--3F, [4](#fig4){ref-type="fig"}A--4E, and [5](#fig5){ref-type="fig"}A--5D(A) Conserved motif (red) of soluble intermembrane space TIM chaperones in the inner N-terminal and outer C-terminal helices. The bar graph indicates the mean hydrophobicity (software Geneious, Biomatters) of the aligned sequences. Sc, *Saccharomyces cerevisiae*; Sp, *Schizosaccharomyces pombe*; Nc, *Neurospora crassa*; At, *Arabidopsis thaliana*; Dm, *Drosophila melanogaster*; Ce, *Caenorhabditis elegans*; Dr, *Danio rerio*; Rn, *Rattus norvegicus*; Mm, *Mus musculus*; Hs, *Homo sapiens*.(B) Magnification of the TIM9·10 cleft constriction interaction face showing in gray the buried residues at position −4 (Tim9 L31 and Tim10 L36) and +4 (Tim9 F63 and Tim10 Y69) and in red the conserved hydrophobic residues of the binding motif.(C) Original data of *tim9* and *tim10* mutant growth phenotypes. Growth was analyzed either on glucose (YPD) or glycerol (YPG) containing agar media at 19°C, 30°C or 37°C. This supplementary figure shows the original data for [Figure 3](#fig3){ref-type="fig"}C and contains data from [Figure 3](#fig3){ref-type="fig"}F for comparison.(D) Original data of *tim9* and *tim10* mutant growth phenotypes in *tim8tim13*ΔΔ background related to [Figure 3](#fig3){ref-type="fig"}E analyzed as described in C.(E) Steady state protein amounts and membrane potential of isolated TIM chaperone mutant mitochondria are comparable to WT. Upper panels: Mitochondria isolated from yeast cells grown at permissive temperature, were analyzed by SDS-PAGE and immunodecoration against indicated antibodies. Lower panels: Membrane potential was assessed by fluorescence quenching and dissipated by the addition of valinomycin.

It was reported that the TIM8·13 complex has overlapping functions to those of the TIM9·10 complex in the transport of precursor proteins through the IMS ([@bib23], [@bib27], [@bib80]). Upon deletion of the redundant TIM8·13 complex, we identified further single point mutations of *tim9* and *tim10* affecting the conserved motif, which are lethal ([Figures 3](#fig3){ref-type="fig"}E and [S3](#figs3){ref-type="fig"}D). Mutations causing the replacement of two residues opposing each other within the cleft between the N- and C-terminal helices V29KV76S(motif position: −11&+11), F33QF70S(−7&+5), or of two adjacent hydrophobic residues L26KV29K(−14&−11), V29KF33Q(−11&−7), and M32KF33Q(−8&−7) for *TIM10* and M21KF24K(−14&−11), L27SY28Q(−8&−7) for *TIM9* aggravated the growth defects of the single mutants ([Figures 3](#fig3){ref-type="fig"}C, 3F, and [S3](#figs3){ref-type="fig"}C) and are all lethal in the *tim8tim13*ΔΔ background ([Figure 3](#fig3){ref-type="fig"}E). In the absence of TIM8·13, the protein amounts of the tested Tim9 and Tim10 mutants are comparable to those in cells harboring the TIM8·13 complex, excluding a compensatory overexpression of TIM9·10 ([Figure S3](#figs3){ref-type="fig"}E). To verify that the mutant TIM9·10 complexes are properly assembled and are not prone to clearance by the i-AAA protease ([@bib4]), we expressed them in bacterial cells. We assessed their oligomerization and structure by gel filtration ([Figure 3](#fig3){ref-type="fig"}G) and NMR analysis (deposited in Mendeley data, see [Key Resource Table](#sec4.1){ref-type="sec"}). All tested mutants including the two Tim10 mutants V29K and M32K, which caused lethality in the absence of the TIM8·13 complex, form a stable hexameric apo chaperone complex.

Mutations Affecting the Conserved Binding Cleft of TIM Chaperones Impair the Binding and the Biogenesis of α-Helical Metabolite Carrier Proteins {#sec2.3}
------------------------------------------------------------------------------------------------------------------------------------------------

To test if mutations in the conserved motif of Tim9 and Tim10 affect the transfer of hydrophobic membrane protein precursors through the IMS, mitochondria were isolated from the viable mutant strains harboring the *tim8tim13*ΔΔ background grown at permissive conditions (19°C--23°C, [Figure S3](#figs3){ref-type="fig"}D). Most mutant mitochondria contained protein amounts comparable to wild-type (WT) and contained assembled TIM22 complex ([Figures S4](#figs4){ref-type="fig"}A and S4B). Tim9~F24K~ mitochondria contained not only reduced levels of inner membrane carrier proteins like Aac2 and Dic1, but also reduced levels of the essential outer membrane β-barrel protein Tom40 causing a lower accumulation of radiolabeled Oxa1 precursor at the TOM complex ([Figure S4](#figs4){ref-type="fig"}C). In contrast to the compromised levels of metabolite carrier proteins observed *in vivo* upon Tim9 and Tim10 mutations ([Figure 3](#fig3){ref-type="fig"}D), the β-barrel assembly pathway is additionally affected in the *tim8tim13*ΔΔ background (Tim9~F24K~, [Figure S4](#figs4){ref-type="fig"}A). To exclude general mitochondrial defects in the other mutants, the mitochondrial membrane potential (Δψ), the import of radiolabeled precursor protein composed of the presequence of *Neurospora crassa* subunit 9 of the ATPase fused to mouse dihydrofolate reductase (pSu9-DHFR) and of F~1~β (Atp2) were monitored. Both the membrane potential and the import of matrix-destined precursor proteins were comparable to wild-type for most of the analyzed mutants ([Figures S3](#figs3){ref-type="fig"}E and [S4](#figs4){ref-type="fig"}D--S4F), except for Tim9~V70S~ and Tim10~F33Q~, which were therefore excluded from further Δψ-dependent analysis.Figure S4Analysis of Mitochondria Expressing *tim9* and *tim10* Variants of the Conserved Motif, Related to [Figures 3](#fig3){ref-type="fig"}E, [4](#fig4){ref-type="fig"}A--4E, and [5](#fig5){ref-type="fig"}A--5D(A) Steady state protein amounts of isolated TIM chaperone mutant mitochondria in *tim8tim13*ΔΔ background. Mitochondria were analyzed as described for [Figure S3](#figs3){ref-type="fig"}E. OM, outer mitochondrial membrane; IMS, intermembrane space; IM, inner mitochondrial membrane; SDH (CII), succinate dehydrogenase (complex II of the respiratory chain); TIM23, presequence translocase of the inner membrane; TIM22, carrier translocase of the inner membrane.(B) Steady state protein complexes of isolated TIM chaperone mutant mitochondria in *tim8tim13*ΔΔ background. Mitochondria isolated from yeast cells grown at permissive temperature, were analyzed by BN-PAGE and immunodecoration against indicated antibodies. CIII~2~-CIV and CIII~2~-CIV~2~, respiratory chain supercomplexes.(C) \[^35^S\]Oxa1 was imported into isolated mitochondria of *tim9* mutants in *tim8tim13*ΔΔ background after dissipation of the membrane potential and analyzed by blue native PAGE. The \[^35^S\]Oxa1-TOM intermediate was quantified by autoradiography (SEM, n = 3 experiments).(D) Mitochondrial membrane potential of TIM chaperone mutant mitochondria is comparable to WT. Membrane potential was assessed as in [Figure S3](#figs3){ref-type="fig"}E.(E) Matrix protein import into TIM chaperone motif mutant mitochondria in *tim8tim13*ΔΔ background. The import of the presequence-carrying matrix protein \[^35^S\]pSu9-DHFR into mitochondria was analyzed on SDS-PAGE followed by autoradiography. p, precursor; i, intermediate; m, mature; Δψ, mitochondrial membrane potential.(F) Analysis of \[^35^S\]F~1~β(ATP2) import as described for E. The mature band was quantified by autoradiography (SEM, n = 3 experiments).

To test the ability of the TIM chaperone complex to bind to metabolite carrier substrate, import of \[^35^S\]Aac2-DHFR was arrested by addition of methotrexate ([@bib57]), which causes stable folding of DHFR and thus blocks the import of the DHFR passenger domain at the TOM channel ([Figures 4](#fig4){ref-type="fig"}A and 4B). Upon binding of the wild-type TIM9·10 chaperone, the Aac2-DHFR precursor is stably arrested at the TOM complex as resolved by blue native PAGE. In contrast, the Aac2-DHFR/TOM intermediate is reduced in the mutants ([Figures 4](#fig4){ref-type="fig"}A and 4B), a finding that is ascribed to the inability of these mutants to stably hold metabolite carrier precursors. When the full import of radiolabeled metabolite carrier and carrier-like proteins was analyzed by blue native PAGE, defects in Aac2 and Tim23 inner membrane protein assembly were observed in the mutants ([Figures 4](#fig4){ref-type="fig"}C--4E). We studied the effects of these mutations on the molecular level by comparing the ability of wild-type and mutant TIM9·10 to form complexes with metabolite carrier precursor protein using the *in vitro* reconstitution approach described above ([Figure 1](#fig1){ref-type="fig"}A). While wild-type TIM forms stable complexes with Ggc1, a single amino acid mutation in each of the Tim9 or Tim10 subunits inhibits complex formation ([Figure 4](#fig4){ref-type="fig"}F). Collectively, these import and binding assays indicate that the affinity of the mutant TIM9·10 chaperones to the carrier precursors is significantly reduced, even though only three out of twelve tentacles of the TIM chaperone complex are affected by a single amino acid exchange.Figure 4Metabolite Carrier Precursor Biogenesis Defects in TIM Chaperone Motif Mutants(A and B) Methotrexate preincubated \[^35^S\]Aac2-DHFR was incubated with isolated mitochondria of *tim9* and *tim10* mutants in *tim8tim13*ΔΔ (A) or indicated background (B) and analyzed by blue native PAGE and autoradiography. In (B), the Aac2-TOM intermediate was quantified by autoradiography (SEM, n = 3 experiments). TOM, translocase of the outer mitochondrial membrane.(C) Import of \[^35^S\]Aac2 analyzed without methotrexate as in (A).(D) \[^35^S\]Aac2 was imported into mitochondria from the indicated background as described in (C) and the major form of the assembled carrier (AAC) was quantified by autoradiography (SEM, n = 3 experiments). Δψ, mitochondrial membrane potential; AAC~(2)~, ADP/ATP carrier~(oligomer)~.(E) Assembly of \[^35^S\]Tim23 analyzed as in (C). TIM23, presequence translocase of the inner membrane.(F) Analysis of wild-type TIM9·10, *tim9*-, and *tim10* mutant complexes as described in [Figure 1](#fig1){ref-type="fig"}A.See also [Figure S4](#figs4){ref-type="fig"}.

TIM Chaperones Are Essential for the Transfer of β-Barrel Membrane Proteins {#sec2.4}
---------------------------------------------------------------------------

The TIM chaperones are also implicated in the import of β-barrel outer membrane proteins ([@bib23], [@bib27], [@bib80]). Import of the most abundant β-barrel protein porin (mammalian VDAC) was monitored by blue native PAGE assembly of \[^35^S\]Por1 ([Figures 5](#fig5){ref-type="fig"}A and 5B) and revealed defects in porin assembly for the TIM chaperone mutants. In addition, all assembly steps of the \[^35^S\]Tom40 β-barrel biogenesis pathway, transfer to the SAM complex (intermediates Ia and Ib), generation of the membrane integral intermediate (Int-II), and assembly into the mature TOM complex, were affected in TIM chaperone mutants ([Figures 5](#fig5){ref-type="fig"}C and 5D). The analysis in the *tim8tim13*ΔΔ background demonstrated that the TIM chaperone system is also essential for the β-barrel membrane protein precursor transfer through the intermembrane space to the SAM complex similar to the role of the TIM chaperones for metabolite carrier biogenesis of the inner membrane. Moreover, the interaction of the VDAC~257--279~ peptide to the TIM9·10 complex is reduced in case of *tim10* mutants ([Figure 5](#fig5){ref-type="fig"}E). Taken together, the in organello and *in vitro* analyses of the TIM chaperone mutants demonstrate that the hydrophobic TIM chaperone motif residues are crucial for the biogenesis of membrane proteins in both mitochondrial membranes. The quantitative comparison of the Tim10~L26Q~ and *tim8tim13*ΔΔ mutants indicates that the biogenesis of the metabolite carrier Aac2 depends mainly on the TIM9·10 complex ([Figures 4](#fig4){ref-type="fig"}B and 4D). In contrast, the biogenesis of the β-barrel proteins porin and Tom40 are supported by both, the TIM8·13 and the TIM9·10 complexes ([Figures 5](#fig5){ref-type="fig"}B and 5D).Figure 5β-Barrel Biogenesis and Chaperone Binding Is Impaired by Mutations in the TIM Chaperone Motif(A and B) Assembly of the porin complex, POR, was studied by incubating \[^35^S\]Por1 with isolated mitochondria of *tim9* and *tim10* mutants in *tim8tim13*ΔΔ (A) or indicated background (B) followed by blue native PAGE and autoradiography analyses. In (B), the assembled POR was quantified by autoradiography (SEM, n = 3 experiments).(C) Assembly of \[^35^S\]Tom40 analyzed as in (A).(D) Assembly of \[^35^S\]Tom40 as described in (B). The area of the Tom40 assembly stages was quantified by autoradiography (SEM, n = 3 experiments). TOM, mature TOM complex; SAM-Ib and SAM-Ia, SAM import intermediates; Int-II, intermediate II.(E) *In vitro* binding of the cyclic VDAC~257--279~ TIM9·10 complexes, studied by NMR-based titration experiments, shows strongly reduced affinity in two Tim10 single point mutations (V29K, F33Q; blue) compared to wild-type TIM9·10 (black).See also [Figure S4](#figs4){ref-type="fig"}.

Precursor Proteins Are Bound as a Dynamic Ensemble with Residual Secondary Structure {#sec2.5}
------------------------------------------------------------------------------------

Having shown the essential role of the precursor protein binding motif *in vivo* and *in vitro*, we derived a complete description of the structure and dynamics of apo TIM9·10 and of the precursor protein-chaperone complex at atomic resolution. We first studied the flexibility (picosecond-to-nanosecond motions) of apo TIM9·10 using backbone ^15^N and ALV ^13^CH~3~ nuclear spin relaxation measurements and molecular dynamics (MD) simulation. The upper part of the inner and outer α helices is rigid, and the "tentacles" are increasingly flexible toward the N and C termini ([Figures 6](#fig6){ref-type="fig"}A--6C, [S5](#figs5){ref-type="fig"}A, and S5B). In the Ggc1-bound state, this pattern of intramolecular flexibility is well conserved. [Figure 6](#fig6){ref-type="fig"}A shows the profiles of the site-specific observable *S*^2^·τ~c~, which is the product of the local order parameter (*S*^2^) that describes the amplitude of motion of a given side chain and the correlation time of the overall molecular tumbling (τ~c~) in apo (black) and Ggc1-bound states (orange). The residue-wise profiles of this parameter are in both states very similar, revealing that the local flexibility of the chaperone remains unchanged upon precursor protein binding. Together with the fact that apo and holo TIM9·10 NMR spectra are highly similar ([Figures 1](#fig1){ref-type="fig"}B and [S1](#figs1){ref-type="fig"}E--S1G), this data confirms that the hexameric TIM9·10 remains structurally unaltered. However, the apo and holo *S*^2^·τ~c~ data differ by a uniform scaling factor of ∼1.9, which points to a ∼2-fold larger overall size of the TIM/precursor complex compared to apo TIM9·10 (see below).Figure 6Dynamics of the TIM9·10/Carrier-Precursor Complex and Conformation of the Bound Precursor(A) ps-to-ns dynamics probed by ALV methyl triple-quantum (3Q) relaxation experiments ([@bib65]) showing the product of local order parameter and overall-tumbling correlation time constant, *S*^2^·τ~c~, for apo (black) and Ggc1-bound TIM9·10 (orange). In the lower panel, the apo data have been multiplied by an overall factor (1.9) minimizing the offset of the two datasets. Error margins were determined from the spectral noise level, used in fitting the 3Q relaxation buildup curves; see [STAR Methods](#sec4){ref-type="sec"}.(B) The data from (A) are plotted on the TIM9·10 structure.(C) Local backbone dynamics probed by ^1^H-^15^N heteronuclear NOE measurements.(D) ^13^C methyl CPMG RD profiles in Ggc1-bound TIM9·10 for three representative residues of TIM9·10 (indicated with an arrow in F) and an Ala correlation peak of Ggc1, obtained at two magnetic-field strengths (700 MHz and 950 MHz ^1^H Larmor frequencies). Non-flat profiles reveal ms dynamics. Error bars are based on spectral noise.(E) Rate constant of the dynamic process obtained from a global fit of CPMG RD data of two independent TIM9·10/Ggc1 samples (orange), methyl-labeled either on TIM9·10 or Ggc1 (indicated by a star), and TIM9·10/Aac3 (red). Error bars were obtained from subjection the RD fit to a Monte Carlo procedure.(F) Structural view of the amplitude of CPMG RD profiles, obtained from the difference of R~2eff~ at the lowest and highest CPMG frequency ν~CPMG~. Residues for which data are shown in (D) are indicated by arrows.(G) ^1^H-^13^C HMQC NMR spectra (Ala-CH~3~) of Ggc1 in DPC detergent (folded), urea (unfolded) and bound to TIM9·10.(H) Transfer kinetics of Aac3(2TM) from an unlabeled holo-TIM9·10 complex to added ALV-labeled apo-TIM9·10. Shown is the evolution of summed peak intensities of residues in the binding cleft (red), which have a strong intensity drop upon binding ([Figure S1](#figs1){ref-type="fig"}G) and on the top of TIM9·10 (black), less impacted by binding. The fitted decay rate constant is ∼4.3 hr.(I) Circular dichroism spectra of apo and precursor protein-loaded TIM9·10.See [Figure S5](#figs5){ref-type="fig"}.Figure S5Dynamics of apo TIM9·10 and Precursor Protein Bound to TIM9·10, Related to [Figures 6](#fig6){ref-type="fig"}C and 6G(A) ^1^H-^15^N heteronuclear NOE effect in apo TIM9·10, shown for all available backbone amide sites in Tim9 (top) and Tim10 (bottom).(B) Graphical representation of the motional amplitudes sampled in an unbiased one-microsecond-long all-atom MD simulation of TIM9·10 using the Amber ff99SB^∗^-ILDN force field. The width of the backbone representation reflects the root mean square fluctuation (RMSF) at residue level averaged over the RMSF values of Tim9 and Tim10 monomers by considering the symmetry.(C) Representative CPMG relaxation dispersion curves of four residues in TIM9·10 in apo and holo states.(D) ^1^H-^15^N NMR spectra of deuterated carrier precursor proteins bound to unlabeled TIM9·10. Left: ^1^H-^15^N BEST-TROSY ([@bib20]) spectrum of Aac3(2TM) bound to TIM9·10. Middle: ^1^H-^15^N CRINEPT-TROSY ([@bib54]) of Ggc1 bound to TIM9·10 recorded in an overnight experiment at 35°C. The sensitivity of an INEPT-based TROSY experiment was significantly lower without providing additional cross-peaks (data not shown). Right: Overlay of ^1^H-^15^N correlation spectra of Ggc1 solubilized in 8 M urea (blue), where it is unfolded, approx. 50 mM dodecylphosphocholine (DPC), where it forms primarily helical structure (gray) ([@bib39]) and bound to TIM9·10 (orange). Insert in right spectrum: ^1^H-^13^C HMQC spectrum of the Ile-δ1 sites in Ggc1 (labeled at methyls of Ile-δ1 and Ala-β). The Ala part of this spectrum is displayed in [Figure 6](#fig6){ref-type="fig"}G. In the urea-unfolded state, Ggc1 shows very sharp resolved peaks and a narrow ^1^H peak dispersion, both typical for a fully flexible random-coil state. The broader dispersion in the DPC-refolded state, points to a more compact arrangement with at least some tertiary contacts. The comparison to these states allows us to exclude that Ggc1 bound to TIM is a fully flexible 'random coil' state, and it indicates a substantial degree of conformational heterogeneity. Note that across the accessible range of temperatures (ca. 5 to 50°C), the spectra quality does not significantly change, indicating the presence of μs-ms exchange over these temperatures, and excluding more advanced NMR experiments for site-specific analyses of secondary structure.All error margins shown in (A) and (C) were determined from 3 times the spectral noise level.

We then probed the interaction dynamics of precursor proteins with TIM9·10 using Carr-Purcell-Meiboom-Gill (CPMG) relaxation-dispersion (RD) experiments ([@bib36]), which sense motions on microsecond-to-millisecond (μs-ms) timescales. When precursor protein (Aac3 or Ggc1) was bound to the chaperone, residues located in the binding cleft of TIM9·10 experienced μs-ms motions, as evidenced by non-flat RD profiles ([Figure 6](#fig6){ref-type="fig"}D); quantitative analysis shows that this motion occurred on a 0.8 ms (Aac3) to 1.3 ms (Ggc1) timescale ([Figure 6](#fig6){ref-type="fig"}E). In apo TIM9·10, these sites did not undergo ms motions ([Figure S5](#figs5){ref-type="fig"}C), establishing that the observed dynamics are directly linked to the chaperone/precursor protein interactions.

To gain further insight into this dynamic interaction, we studied the precursor protein conformation and dynamics. [Figure 6](#fig6){ref-type="fig"}G shows the NMR spectrum of the Ala methyl groups of Ggc1 bound to TIM9·10, and [Figure S5](#figs5){ref-type="fig"}D shows additional backbone amide and methyl spectra of Ggc1 and Aac3. The precursor protein spectra clearly differ from those of the fully unfolded state in urea, but also from the conformation of the refolded state in detergent where it forms predominantly α helices ([@bib39]). The broad resonance lines point to exchange dynamics between various conformations. To probe the presence of the precursor dynamics directly, we used CPMG NMR measurements of Ala and Ile methyl sites in Ggc1 bound to TIM9·10. While the low resolution of the methyl resonances, due to heterogeneity and dynamics, prohibits site-specific analysis, the CPMG data of the methyl resonances establish that the bound carrier undergoes motions on a timescale of ∼1.3 ms ([Figures 6](#fig6){ref-type="fig"}D and 6E). This timescale matches quantitatively the one sensed by the residues in the binding cleft on the chaperone ([Figure 6](#fig6){ref-type="fig"}E), supporting the notion that we are observing intermolecular dynamics.

The dynamic process may correspond to (1) conformational rearrangements within the complex ("bound motion"), or (2) disruption and re-formation of the complex ("on/off"). The latter model would imply that precursor protein exists (transiently) freely in solution before rebinding to TIM. The existence of "on/off" dynamics can be probed by analyzing if precursor protein can be transferred between TIM chaperones. Transfer of the precursor was probed by mixing NMR-visible (labeled) apo-TIM9·10 with unlabeled holo-complex and following the NMR intensity drop ([Figures S1](#figs1){ref-type="fig"}E--S1G) associated to binding of precursor to the labeled chaperone. [Figure 6](#fig6){ref-type="fig"}H shows such intensity time traces, revealing that the transfer process occurs on a timescale of ∼4 hr ([Figure 6](#fig6){ref-type="fig"}H), i.e., ∼7 orders of magnitude longer than the observed ms dynamics, allowing us to unambiguously ascribe the observed ms dynamics to motions within the complex. The slow transfer of precursor protein and the long-time stability of our samples (weeks) suggest a high affinity.

The dynamic nature of the bound precursor protein and the associated broadening of NMR lines ([Figure S5](#figs5){ref-type="fig"}D) preclude site-specific analyses of the secondary structure at the residue level. To gain insight into the precursor protein conformation in the complex, we applied circular dichroism (CD) spectroscopy ([Figure 6](#fig6){ref-type="fig"}I). The apo TIM9·10 CD spectrum is in good agreement with the known hexameric structure consisting of α helices with flexible ends. When either Aac3 or Ggc1 are bound, the α-helical signature becomes more pronounced. In principle, the additional α-helical structure in complex samples compared to apo-TIM may be ascribed to extended α-helical structure in the chaperone or α-helical structure of the bound precursor or both. Based on the fact that NMR spectra ([Figures S1](#figs1){ref-type="fig"}E--S1G) and internal dynamics ([Figure 6](#fig6){ref-type="fig"}A) of TIM9·10 remain unchanged upon precursor protein binding, we can exclude significant structural changes of the chaperone, allowing us to ascribe the increased α-helix CD signature to partial α-helical conformations of the bound precursor.

TIM Chaperones Hold Precursor Proteins in a Dynamic Elongated State {#sec2.6}
-------------------------------------------------------------------

To gain an overall structural view of the complex, we determined the TIM/precursor protein stoichiometry from the sedimentation and translational diffusion coefficients of apo and holo complexes by analytical ultra-centrifugation (AUC) and diffusion-ordered NMR (DOSY). Our observations revealed consistently that the ∼35 kDa carrier precursor protein recruits two TIM9·10 hexamers ([Figures 7](#fig7){ref-type="fig"}A and 7B). This 2:1 (TIM complex:precursor protein) stoichiometry is corroborated by the observation that the rotational diffusion correlation time of the holo complex, τ~c~, is ∼1.9-fold higher than the one of apo TIM9·10 ([Figure 6](#fig6){ref-type="fig"}A). Furthermore, analyses of band intensities on SDS-PAGE gels of 27 independent TIM9·10/Ggc1 samples further confirm the 2:1 molar ratio ([Table S1](#mmc1){ref-type="supplementary-material"}).Figure 7Architecture of the TIM/Metabolite Carrier Complexes(A) Analytical ultracentrifugation profiles reveal the stoichiometry of TIM9·10/carrier precursor complexes.(B) Translational diffusion coefficients of apo and holo TIM9·10 determined by diffusion ordered NMR. Error bars were from Monte Carlo analysis of the diffusion-data fit and the spectral noise level.(C) Pair distance distributions obtained by taking an indirect Fourier transform of the experimental and back-predicted SAXS curves. The solid orange line shows the results from analyzing the back-calculated SAXS data from the ensemble of TIM9·10/Ggc1 conformations obtained from coarse-grained molecular dynamics. A view of the latter ensemble is provided in (E).(D) Molecular envelope of TIM9·10/Ggc1 obtained from SAXS data.(E) The most populated structures of the TIM9·10/Ggc1 complex from the coarse-grained molecular dynamics ensemble. The middle pie chart shows the population of the top 12 clusters which together occupy ∼80% of the conformational space in total. The cartoon structures of these clusters are shown next to each chart.See [Figure S6](#figs6){ref-type="fig"}.

We reasoned that the observed stoichiometry must be dependent on the precursor protein size and prepared complexes of a truncated construct of Aac3 comprising only two transmembrane segments, Aac3(2TM). Indeed, AUC and DOSY data revealed that this shorter precursor chain recruits only a single TIM9·10 hexamer ([Figures 7](#fig7){ref-type="fig"}A and 7B).

To gain a structural view of this complex, we turned to small-angle X-ray scattering (SAXS). The larger size of the complex, compared to apo TIM9·10 is readily visible from the pair distribution function ([Figure 7](#fig7){ref-type="fig"}C) and the raw scattering data ([Figures S6](#figs6){ref-type="fig"}A--S6D). The envelope of the TIM9·10/Ggc1 complex ([Figure 7](#fig7){ref-type="fig"}D) shows two spherical densities matching two hexameric TIM chaperones. Two void volumes point to an unoccupied central cavity in each hexameric TIM, confirming that the central cavity is not involved in binding.Figure S6SAXS Data of TIM9·10 and TIM9·10/Ggc1 Complexes and Molecular Dynamics Analysis, Related to [Figures 7](#fig7){ref-type="fig"}C and 7E(A) Guinier analysis of the SAXS data of apo TIM9·10 (black) and TIM9·10/Ggc1 (orange).(B) The experimental scattering curves of apo TIM9·10 (black) and TIM9·10/Ggc1 complexes (orange) are compared with the scattering curves back-calculated from the reweighted all-atom MD ensemble of apo TIM9·10 and coarse-grained MD ensemble of the TIM9·10/Ggc1 complex, respectively. The χ^2^ values between experimental curves and calculated curves of reweighted MD ensemble are 8.6 and 6.1 for the apo and holo TIM complexes, respectively.(C and D) show the Kratky plots and the pair-distance distributions transformed from the scattering data. Note that the deviation for the apo TIM9·10 hexamer might be caused by the imperfection of the current force field.(E) Eight different initial models of the TIM9·10/Ggc1 complex used for coarse-grained MD simulations.(F-I) SAXS guided MD ensemble refinement of the apo TIM9·10 hexamer F, G and the TIM9·10/Ggc1 complex H, I using the maximum entropy approach. F and H show χ2 as a function of the relative entropy Srel. G and I show χ2 as a function of the 'temperature-like' free parameter θ. The gray lines indicate the resulted χ2 and Srel with a proper choice of θ.

Data-Guided Molecular Dynamic Simulations Reveal a Dynamic Ensemble {#sec2.7}
-------------------------------------------------------------------

We derived an ensemble description of this highly dynamic complex by integrating the information from all NMR and SAXS data into molecular dynamics simulations. Briefly, we constructed different conformations of the TIM9·10/Ggc1 complex by placing two TIM hexamers into the SAXS-envelope and placing the preprotein using the NMR data as restraints and performed coarse-grained molecular dynamics simulations to sample a large conformational space ([Video S1](#mmc5){ref-type="supplementary-material"}). The conformational distribution was subsequently reweighted to match the SAXS data using an ensemble refinement method ([Figures S6](#figs6){ref-type="fig"}F--S6I). In the ensemble of structures ([Figure 7](#fig7){ref-type="fig"}E) the precursor protein is wrapped into the clamp-like binding sites of two hexameric modules, makes extensive contacts to the hydrophobic motif, and dynamically samples multiple conformations. The precursor protein adopts an elongated conformation holding the two chaperone hexamers in a modular "bead-on-a-string" architecture.

Video S1. Dynamic Interaction of TIM9·10 with Ggc1 from Coarse-Grained Molecular Dynamics Simulations, Related to Figure 7The eight models have been obtained from the different starting conformations shown in Figure S6E.

Discussion {#sec3}
==========

Chaperones of membrane proteins transport highly aggregation-prone polypeptides to their insertases. Premature release of these precursors would lead to protein aggregation with detrimental cellular consequences. Our study reveals that polypeptides belonging to classes of α-helical and β-barrel membrane proteins bind to the same binding cleft of the TIM chaperone. Conserved hydrophobic residues in this cleft are crucial for precursor protein binding and transfer through the intermembrane space. We further found that TIM chaperones comprising a single point mutation in Tim9 or Tim10 subunits are unable to hold precursor proteins, compromising yeast growth and viability. The binding site revealed in this study allows rationalizing why the premature stop at codon 80 of the human Tim8 analog, which prevents synthesis of leucine 81 corresponding to the position +15 of the hydrophobic motif, leads to import defects causing deafness dystonia syndrome, similarly to all larger truncations of the Tim8a protein ([@bib35], [@bib69]).

Different precursors have a variable dependence on the TIM9·10 versus the TIM8·13 complex. While the intermembrane space transfer of the two major β-barrel proteins of the outer membrane porin and Tom40 depends on both "transfer-chaperone" complexes, binding and transfer of the metabolite carrier Aac2 depends predominantly on TIM9·10. Similarly, we observed a strong dependence of the carrier-like precursor Tim23 on the TIM9·10 complex, excluding a specific role of the TIM8·13 complex for Tim23 biogenesis ([@bib48], [@bib14], [@bib16], [@bib5]).

Multiple Weak Binding Sites Enable High Affinity with Efficient Downstream Release {#sec3.1}
----------------------------------------------------------------------------------

In addition to the requirement for tight binding, "transfer-chaperones" need to enable the release of their "client" protein in a conformation that enables downstream membrane insertion. Our integrated structural/dynamical data show that precursor proteins achieve their tight interaction to the chaperone by sampling a multitude of conformations within the binding cleft, with a lifetime of ∼1 ms. This is orders of magnitude faster than the timescale required for the mitochondrial precursor protein import and assembly (seconds to min). The rapid interconversion of the precursor between a manifold of bound states points to the existence of multiple interactions, each individually weak, which together result in a high total affinity, as required for a stable transfer chaperone complex. The compatibility of high affinity with extreme mobility has been shown even for two intrinsically disordered proteins ([@bib6]).

We propose that the multiple weak and constantly reshuffling interactions allow efficient release to the insertase. According to the structural view provided here, parts of the precursor protein may transiently detach from the complex and engage with the insertase. The release of the remaining chain of the precursor protein upon membrane insertion can then proceed without significant free-energy barrier by gradually disengaging the multiple weak interactions ([@bib11]). While transfer of precursor from one TIM to another (no free-energy difference involved) takes ∼4 hr, the release at the insertase is likely much faster due to the released free energy upon membrane insertion.

Transfer of Membrane Protein Precursors with Partial Secondary Structure {#sec3.2}
------------------------------------------------------------------------

Currently, structural data on a membrane-protein/chaperone complex is available for the bacterial Skp chaperone encapsulating outer membrane protein (OMP) precursors in a central cavity in a highly dynamic random-coil-like compact state ([@bib11], [@bib60], [@bib73]). Likewise, the periplasmic DegP protease/chaperone also harbors a compact conformation of β-barrel precursor proteins in the central cavity ([@bib37]). Our analysis of the eukaryotic TIM "transfer-chaperone" reveals a different principle for membrane-protein transfer, involving binding to the "transfer-chaperone" at specific equally spaced clamp-like binding motifs on the outside rather than in a central cavity. Furthermore, unlike the random-coil state of bacterial OMP precursors bound to Skp, full-length metabolite carrier precursors form likely partial α-helical secondary structure in a dynamic exchange of conformations. Likewise, formation of β-hairpin structure appears to be a prerequisite for mitochondrial outer-membrane precursor proteins to bind to TIM.

It has been shown that TOM and SAM form a supercomplex with a direct relay of β-barrel membrane protein precursors from the translocase to the insertase ([@bib52]). Therefore, stable full-length β-barrel membrane precursor protein/TIM chaperone complex formation is not required *in vivo*. The fact that complex formation under *in vitro* conditions was possible only for carrier preproteins but not β-barrel precursors suggests a lower binding affinity and may be related to the fact that β-barrel biogenesis does not depend on external energy sources ([@bib25]), in contrast to the membrane-potential dependent insertion into the inner membrane. The β-hairpin conformation of the bound outer-membrane precursor, a prerequisite for binding to TIM, is ideally suited for β-barrel membrane protein insertion by the SAM complex ([@bib26]). The preformed β-hairpin conformation on the TIM "transfer-chaperones" suggests that the Sam50 POTRA domain is not essential for mitochondrial β-barrel protein biogenesis in contrast to the bacterial β-barrel biogenesis ([@bib7], [@bib24], [@bib40]), where the β-barrel precursor proteins are transported in an unstructured random-coil-like state ([@bib11]).

The chaperone-to-precursor stoichiometry depends on the length of the transported polypeptide. This modular architecture, reported also for other unrelated chaperones ([@bib58], [@bib60]), allows the TIM system to handle the wide range of incoming precursor chains, from ∼17 kDa (Tim17) to 50 kDa (Sal1, Sam50).

TIM "Transfer-Chaperones" Mimic Co-translational Membrane Insertion {#sec3.3}
-------------------------------------------------------------------

Taken together, the TIM "transfer-chaperones" provide multiple clamp-like binding sites to hold the precursors in an elongated conformation and to keep the hydrophobic transmembrane domains apart from each other. The TIM chaperones have the remarkable property to bind precursors containing preformed elements of both secondary structure classes, which provides an ideal prerequisite for subsequent membrane insertion. The segmental transfer mechanism maintains the precursor in a translocation competent "nascent chain-like" conformation and enables efficient translocation by the membrane insertion machineries. The mitochondrial TIM "transfer-chaperone" system thus mimics elements of co-translational membrane insertion, providing a paradigm for chaperone-guided membrane protein insertion in ribosome-free compartments such as the mitochondrial and chloroplast intermembrane spaces.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Rabbit polyclonal anti-Tom70 (GR657-4)Nils WiedemannN/ARabbit polyclonal anti-Tom40 (168-4)Nils WiedemannN/ARabbit polyclonal anti-Tom22 (GR3227-2)Nils WiedemannN/ARabbit polyclonal anti-Tom5 (GR3420-7)Nils WiedemannN/ARabbit polyclonal anti-Om45 (GR1390-4)Nils WiedemannN/ARabbit polyclonal anti-Sam50 (312-7)Nils WiedemannN/ARabbit polyclonal anti-Por1 (GR3622-3)Nils WiedemannN/ARabbit polyclonal anti-Sdh1 (GR1849-3)Nils WiedemannN/ARabbit polyclonal anti-Ssc1 (119-5)Nils WiedemannN/ARabbit polyclonal anti-Mdj1 (GR1839-7)Nils WiedemannN/ARabbit polyclonal anti-Tim54 (GR2012-5)Nils WiedemannN/ARabbit polyclonal anti-Tim23 (GR3878-4)Nils WiedemannN/ARabbit polyclonal anti-Tim22 (164-8)Nils WiedemannN/ARabbit polyclonal anti-Tim13 (GR2044-5)Nils WiedemannN/ARabbit polyclonal anti-Tim10 (217-8)Nils WiedemannN/ARabbit polyclonal anti-Tim9 (GR2013-7)Nils WiedemannN/ARabbit polyclonal anti-Aac2 (GR3617-7)Nils WiedemannN/ARabbit polyclonal anti-Dic1 (GR2055-KB)Nils WiedemannN/ARabbit polyclonal anti-Yhm2 (GR3053-5)Nils WiedemannN/ARabbit polyclonal anti-Cox1 (GR1538-4)Nils WiedemannN/ARabbit polyclonal anti-Tim12 (GR905-AP)Nils WiedemannN/AAnti-Rabbit IgG (whole molecule)-peroxidase, antibody produced in goatSigma-AldrichCat. \#A6154; RRID:[AB_258284](nif-antibody:AB_258284){#interref0010}Monoclonal Anti-polyHistidine−Peroxidase antibody produced in mouseSigma-AldrichCat. \#A7058; RRID:[AB_258326](nif-antibody:AB_258326){#interref0015}**Bacterial and Virus Strains**XL-1 Blue *Escherichia coli*StratageneCat. \#200158SHuffle® T7 Competent CellsNEBCat. \#C3026JBL21(DE3) Chemically Competent CellsSigma-AldrichCat. \#CMC0014XL1-Blue Supercompetent CellsStratagene/AgilentCat. \#200236**Chemicals, Peptides, and Recombinant Proteins**Q5 High-Fidelity DNA PolymeraseNEBCat. \#M0492SDPNINEBCat. \#R0176SNourseothricin DihydrogensulfatRothCat. \#3011.3Hygromycin BRothCat. \#CP13.3Polyethylene glycol (PEG4000)Merck MilliporeCat. \#1097270100SC amino acids without tryptophanMP BiomedicalsCat. \#4511-022SC amino acids without uracilMP BiomedicalsCat. \#4511-222Yeast nitrogen base without amino acidsBecton DickinsonCat. \#291920AgarBecton DickinsonCat. \#214030GlucoseRothCat. \#6780.15-Fluoroorotic acid (5FOA)MelfordCat. \#F10501-10.0UracilFluka AnalyticalCat. \#94220Yeast extractBecton DickinsonCat. \#212720Bacto peptoneBecton DickinsonCat. \#211820GlycerolHoneywellCat. \#G7757-1GAZymolyase 20TNacalai tesque INC.Cat. \#07663-91Digitonin WSMATRIX BioScienceCat. \#60105^35^S-methioninePerkin ElmerCat. \#NEG009T005MC3,3′-dipropylthiadicarbocyanine iodide (DiSC3)InvitrogenCat. \#D306Cyclic VDAC beta hairpin peptide[@bib31]Doron RapaportLinear VDAC beta hairpin peptide[@bib31]Doron RapaportAla^β^ CH~3~ labeling reagentsNMR-Bio, <http://nmr-bio.com>SLAM-A^β^ kitLeu^proS^ + Val^proS^ CH~3~ labeling reagentsNMR-Bio, <http://nmr-bio.com>DLAM-^LVproS^ kitAla^β^ + Ile^β^ CH~3~ labeling reagentsNMR-Bio, <http://nmr-bio.com>DLAM-A^β^/I^δ1^ kit(1-oxyl-2,2,5,5-tetramethyl-Δ3-pyrroline-3-methyl)-methanethiosulfonate)Toronto Research ChemicalsCat. \#O875000**Critical Commercial Assays**TNT SP6 quick coupled kitPromegaCat. \#L2080Rabbit Reticulocyte Lysate SystemPromegaCat. \#L4540mMESSAGE mMACHINE SP6 kitInvitrogeneCat. \#AM1340**Deposited Data**TIM9⋅10 NMR assignmentBioMagResBank, <http://www.bmrb.wisc.edu>BMRB: 27052SAXS data and complex models from MDSASBDB, <https://www.sasbdb.org>SASDEF2 (TIM9·10) SASDEG2 (TIM9·10/Ggc1)CPMG relaxation dispersion dataMendeley data<https://doi.org/10.17632/k6d77j8vzp.1>Chemical-shift perturbation of Tim10-mutants F33Q and V29KMendeley data<http://dx.doi.org/10.17632/c9bp4dt5bz.1>Methyl order parameter measurements from relaxation-violated coherence transfer NMRMendeley data<https://doi.org/10.17632/cn9j8wtndj.1>**Experimental Models: Organisms/Strains**YPH499 *MAT*a *ura3-52 lys2-801_amber ade2-101_ochre trp1-Δ63 his3-Δ200 leu2-Δ1*LGC Standards/ATCC<http://www.atcc.org/?geo_country=us>YPH499 *tim9::ade2* \[Yep352-MET25pr-Tim9-CYC1t\][@bib3]yNW-5080YPH499 *tim10::ade2* \[Yep352-MET25pr-Tim10-CYC1t\][@bib68]yNW-5081YPH499 *tim9::ade2 tim8::natNT2 tim13::hphNT1* \[Yep352-MET25pr-Tim9-CYC1t\]This paperyNW-5082YPH499 *tim10::ade2 tim8::natNT2 tim13:: hphNT1* \[Yep352-MET25pr-Tim10-CYC1t\]This paperyNW-5083YPH499 *tim9::ade2* \[pFL39-Tim9\]This paperyNW-5117YPH499 *tim10::ade2* \[pFL39-Tim10\]This paperyNW-5118YPH499 *tim9::ade2 tim8::natNT2 tim13::hphNT1* \[pFL39-Tim9\]This paperyNW-5119YPH499 *tim10::ade2 tim8::natNT2 tim13::hphNT1* \[pFL39-Tim10\]This paperyNW-5084YPH499 *tim10::ade2 tim8::natNT2 tim13::hphNT1* \[pFL39-Tim10~L26Q~\]This paperyNW-5206YPH499 *tim10::ade2 tim8::natNT2 tim13::hphNT1* \[pFL39-Tim10~V29S~\]This paperyNW-5085YPH499 *tim10::ade2 tim8::natNT2 tim13::hphNT1* \[pFL39-Tim10~M32S~\]This paperyNW-5086YPH499 *tim10::ade2 tim8::natNT2 tim13::hphNT1* \[pFL39-Tim10~F33Q~\]This paperyNW-5087YPH499 *tim10::ade2 tim8::natNT2 tim13::hphNT1* \[pFL39-Tim10~V76S~\]This paperyNW-5090YPH499 *tim10::ade2 tim8::natNT2 tim13::hphNT1* \[pFL39-Tim10~F70S~\]This paperyNW-5207YPH499 *tim9::ade2 tim8::natNT2 tim13::hphNT1* \[pFL39-Tim9~M21K~\]This paperyNW-5094YPH499 *tim9::ade2 tim8::natNT2 tim13::hphNT1* \[pFL39-Tim9~F24K~\]This paperyNW-5096YPH499 *tim9::ade2 tim8::natNT2 tim13::hphNT1* \[pFL39-Tim9~L27K~\]This paperyNW-5208YPH499 *tim9::ade2 tim8::natNT2 tim13::hphNT1* \[pFL39-Tim9~V70S~\]This paperyNW-5100YPH499 *tim9::ade2 tim8::natNT2 tim13::hphNT1* \[pFL39-Tim9~L64S~\]This paperyNW-5099YPH499 *tim10::ade2* \[pFL39-Tim10~L26K~\]This paperyNW-5209YPH499 *tim10::ade2* \[pFL39-Tim10~L26Q~\]This paperyNW-5210YPH499 *tim10::ade2* \[pFL39-Tim10~V29K~\]This paperyNW-5106YPH499 *tim10::ade2* \[pFL39-Tim10~V29S~\]This paperyNW-5107YPH499 *tim10::ade2* \[pFL39-Tim10~M32K~\]This paperyNW-5108YPH499 *tim10::ade2* \[pFL39-Tim10~M32S~\]This paperyNW-5214YPH499 *tim10::ade2* \[pFL39-Tim10~F33Q~\]This paperyNW-5109YPH499 *tim10::ade2* \[pFL39-Tim10~V29KV76S~\]This paperyNW-5112YPH499 *tim10::ade2* \[pFL39-Tim10~V76S~\]This paperyNW-5122YPH499 *tim10::ade2* \[pFL39-Tim10~M80K~\]This paperyNW-5211YPH499 *tim10::ade2* \[pFL39-Tim10~F70S~\]This paperyNW-5120YPH499 *tim10::ade2* \[pFL39-Tim10~V76K~\]This paperyNW-5212YPH499 *tim10::ade2* \[pFL39-Tim10~F33QF70S~\]This paperyNW-5115YPH499 *tim9::ade2* \[pFL39-Tim9~M21K~\]This paperyNW-5126YPH499 *tim9::ade2* \[pFL39-Tim9~F24K~\]This paperyNW-5127YPH499 *tim9::ade2* \[pFL39-Tim9~M21KF24K~\]This paperyNW-5129YPH499 *tim9::ade2* \[pFL39-Tim9~L27K~\]This paperyNW-5213YPH499 *tim9::ade2* \[pFL39-Tim9~Y28Q~\]This paperyNW-5131YPH499 *tim9::ade2* \[pFL39-Tim9~L27SY28Q~\]This paperyNW-5132YPH499 *tim9::ade2* \[pFL39-Tim9~V70S~\]This paperyNW-5135YPH499 *tim9::ade2* \[pFL39-Tim9~L64S~\]This paperyNW-5134**Oligonucleotides**See [Table S3](#mmc3){ref-type="supplementary-material"}This study/EurofinsN/A**Recombinant DNA**pFL39Tim9Nils WiedemannpNW-2917pFL39Tim10Nils WiedemannpNW-2814pFL39Tim9~M21K~This paperpNW-2918pFL39Tim9~M21S~This paperpNW-2919pFL39Tim9~F24K~This paperpNW-2920pFL39Tim9~M21KF24K~This paperpNW-2921pFL39Tim9~L27K~This paperpNW-2922pFL39Tim9~Y28Q~This paperpNW-2923pFL39Tim9~L27SY28Q~This paperpNW-2924pFL39Tim9~V70S~This paperpNW-2925pFL39Tim9~V70K~This paperpNW-2926pFL39Tim9~F74K~This paperpNW-2927pFL39Tim9~L64S~This paperpNW-2928pFL39Tim10~V29K~This paperpNW-2816pFL39Tim10~V29S~This paperpNW-2817pFL39Tim10~M32K~This paperpNW-2818pFL39Tim10~M32S~This paperpNW-2819pFL39Tim10~F33Q~This paperpNW-2820pFL39Tim10~M32KF33Q~This paperpNW-2821pFL39Tim10~F33QF70S~This paperpNW-2827pFL39Tim10~V29KV76S~This paperpNW-2825pFL39Tim10~V76S~This paperpNW-2831pFL39Tim10~V76K~This paperpNW-2929pFL39Tim10~L26K~This paperpNW-2836pFL39Tim10~L26Q~This paperpNW-2839pFL39Tim10~F70S~This paperpNW-2829pFL39Tim10~M80K~This paperpNW-2838pFL39Tim10~L26KV29K~This paperpNW-3097pFL39Tim10~V29KF33Q~This paperpNW-3098pGEM-4Z-Tom40Nils WiedemannpNW-1495pGEM-4Z-Aac2Nils WiedemannpNW-1039pGEM-4Z-Aac2-DHFRNils WiedemannpNW-1253pGEM-3Z-pSu9-DHFRNils WiedemannpNW-S02pSP64-F1βNils WiedemannpNW-F01pGem-4Z-Tim23Nils WiedemannpNW-M36pFA6a-hphNT1[@bib30]<http://www.euroscarf.deindex.php?name=News>pFA6a-natNT2[@bib30]<http://www.euroscarf.deindex.php?name=News>pETDuet-1 TIM9⋅10This paperpPS-TIM910_001pET21a(+) Ggc1[@bib39]pPS-Ggc1_001pET21a(+) Ggc1~C222S~GeneCust/Paul SchandapPS-Ggc1_E2pET21a(+) Ggc1~C222S/C8Q~GeneCust/Paul SchandapPS-Ggc1_F6pET21a(+) Aac3GenScript/Paul SchandapPS-Aac3CtoAS_001pET21a(+) Aac3(TM2)GenScript/Paul SchandapPS-Aac3TM23CtoA_001pETDuet-1 TIM9⋅10~V29K~GeneCust//Paul SchandapPS-TIM910_003pETDuet-1 TIM9⋅10~M32K~GeneCust/Paul SchandapPS-TIM910_002pETDuet-1 TIM9⋅10~F33Q~GeneCust/Paul SchandapPS-TIM910_004pETDuet-1 TIM9⋅10~F33Q/F70S~GeneCust/Paul SchandapPS-TIM910_005pETDuet-1 TIM9~V70K~ ⋅10GeneCust/Paul SchandapPS-TIM910_010pETDuet-1 TIM9~F74K~ ⋅10GeneCust/Paul SchandapPS-TIM910_011**Software and Algorithms**CCPNMR, version 2.4[@bib72]<https://www.ccpn.ac.uk/v2-software/software/analysis>Bruker Topspin, version 3.5Bruker BiospinV 3.5nmrPipe[@bib17]<http://nmrpipe.com/>ChemExGuillaume Bouvignies<https://github.com/gbouvignies/chemex>MODELER, version 9.18[@bib76]<https://salilab.org/modeller/>ATSAS package (GNOM, Primus)[@bib66]<https://www.embl-hamburg.de/biosaxs/download.html>BME[@bib8]<https://github.com/sbottaro/bme>GROMACS 5.1.4[@bib1]<http://www.gromacs.org/>PLUMED 2.3[@bib67]<http://www.plumed.org/>PULCHRA[@bib55]<http://www.pirx.com/pulchra/>Crysol3[@bib21]<https://www.embl-hamburg.de/biosaxs/crysol.html>FoxS[@bib61]<https://modbase.compbio.ucsf.edu/foxs/>WAXSiS[@bib33]<http://waxsis.uni-goettingen.de/>Image Analyzer LAS-4000FujifilmImage Reader V 1.12Typhoon FLA7000GE HealthcareImage Reader V 2.1Multi GaugeFujifilmV 3.2Geneious ProBiomattersV 5.4.3AB2 Luminescence SpectrometerThermo ElectronV 5.5Pymol, version 1.8Schrödinger<https://pymol.org/2/>

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Paul Schanda (<paul.schanda@ibs.fr>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

For all *in vitro* experiments (in-vitro complex formation, NMR, SAXS, cross-linking), TIM9·10 chaperones and precursor proteins were produced in *Escherichia coli*, either in the strain BL21(DE3), for carrier precursor proteins, or in Shuffle T7, for TIM9·10 proteins, as described in detail in the respective sections.

*S. cerevisiae* strains in this study were YPH499 (genotypes listed in [Key Resources Table](#sec4.1){ref-type="sec"}). Cells were grown in YPG (3% glycerol) medium at permissive temperature (19-23°C). Alternatively for *in vivo* heat shock, yeast cells were grown in YPG medium for 6 h at 21°C and then shifted to 37°C for 14 h.

Methods Details {#sec4.4}
---------------

### Protein constructs of TIM9·10 and carrier precursor proteins used for *in vitro* experiments {#sec4.4.1}

Plasmids for production of protein samples in *E. coli* containing the respective sequences of TIM9·10 and precursor proteins were purchased from GeneCust and Genscript. The cysteine residues of the wild-type precursor protein sequences, Ggc1, Aac3, Aac3(2TM), were replaced by either Ala or Ser residues. The respective protein sequences used in the *in vitro* experiments are listed below.Tim9: MDALNSKEQQEFQKVVEQKQMKDFMRLYSNLVERCFTDCVNDFTTSKLTNKEQTCIMKCSEKFLKHSE RVGQRFQEQNAALGQGLGRTim10: MGSSHHHHHHSQDPENLYFQ**[G]{.ul}**SFLGFGGGQPQLSSQQKIQAAEAELDLVTDMFNKLVNNCYKKCINTSYSEGELNKNESSCLDRCVAKYFETNVQVGENMQKMGQSFNAAGKF, the cleavage of the N-terminal His-tag results in a sequence starting with the glycine highlighted in bold/underlined (the wild-type sequence starts with MSFL...).Ggc1 (containing the mutation C222S): MPHTDKK**[Q]{.ul}**SGLARLLGSASAGIMEIAVFHPVDTISKRLMSNHTKITSGQELNRVIFRDHFSEPLGKRLFTLFPGLGYAASYKVLQRVYKYGGQPFANEFLNKHYKKDFDNLFGEKTGKAMRSAAAGSLIGIGEIVLLPLDVLKIKRQTNPESFKGRGFIKILRDEGLFNLYRGWGWTAARNAPGSFALFGGNAFAKEYILGLKDYSQATWSQNFISSIVGA**[S]{.ul}**SSLIVSAPLDVIKTRIQNRNFDNPESGLRIVKNTLKNEGVTAFFKGLTPKLLTTGPKLVFSFALAQSLIPRFDNLLSKLEHHHHHH

This sequence was used for all *in vitro* experiments with Ggc1, except for the paramagnetic labeling experiments for which, we also used the wild-type sequence, containing the native Cys at position 222, and a sequence containing C222S/Q8C mutation. These positions are highlighted above in bold face and underlined.Aac3: MASMTGGQQMGRGSHHHHHHHHHHLVPMSSDAKQQETNFAINFLMGGVSAAIAKTAASPIERVKILIQNQDEMIKQGTLDKKYSGIVDAFKRTAKQEGLISFWRGNTANVIRYFPTQALNFAFKDKIKLMFGFKKEEGYGKWFAGNLASGGAAGALSLLFVYSLDFARTRLAADAKSSKKGGARQFNGLTDVYKKTLKSDGIAGLYRGFMPSVVGIVVYRGLYFGMFDSLKPLVLTGSLDGSFLASFLLGWVVTTGASTASYPLDTVRRRMMMTSGQAVKYNGAIDALKKIVASEGVGSLFKGSGANILRSVAGAGVISMYDQLQMILFGKKFKAac3(2TM), comprising transmembrane helices 2 and 3 (residues 50-180): HHHHHHGTLDKKYSGIVDAFKRTAKQEGLISFWRGNTANVIRYFPTQALNFAFKDKIKLMFGFKKEEGYGKWFAGNLASGGAAGALSLLFVYSLDFARTRLAADAKSSKKGGARQFNGLTDVYKKTLKSDGIAGLYR

### Buffers mentioned in the descriptions below {#sec4.4.2}

*Buffer A:* 50 mM Tris buffer (tris(hydroxymethyl)aminomethane), pH 7.4, 150 mM NaCl*Buffer B:* Buffer A supplemented with 20 mM imidazole and 0.5 M NaCl.*Buffer C:* Buffer A supplemented with 0.5 M imidazole.*NMR buffer:* 20 mM MES buffer (2-(N-morpholino)ethanesulfonic acid), pH 6.5, 50 mM NaCl

### Cloning, expression and purification of TIM9·10 {#sec4.4.3}

*Saccharomyces cerevisiae TIM9* was cloned via NdeI/XhoI into the MCS2 of pETDuet-1, subsequently *Saccharomyces cerevisiae TIM10* containing a N-terminal TEV (Tobacco etch virus) cleavage site was cloned via BamHI/HindIII into the MCS1.

Tim9 and His-tagged Tim10 were co-expressed in SHuffle T7 *E. coli* cells (New England Biolabs). After induction at OD~600~ 0.8 with 0.5mM IPTG (Isopropyl-β-D-1-thiogalactopyranoside), cells were incubated at 20°C overnight and harvested by centrifugation.

The cell pellet was resuspended in 25 mL buffer A per liter of cell culture and sonicated for 5 min (2 s on / 8 s off at 50% amplitude). After a heat shock for 15 min at 80°C the soluble fraction was separated from the insoluble fraction by centrifugation at 40000 x g for 30 min. The supernatant was loaded on a Ni-NTA affinity column pre-equilibrated with buffer A, then washed with 10 column volumes (CV) buffer B. Hexameric TIM9·10 complex was eluted with buffer C. The His-tag was cleaved overnight in buffer A supplemented with 0.5 mM DTT (1,4-Dithiothreitol) and 0.5 mM EDTA (ethylene diaminetetraacetic acid) by adding 1 mg TEV protease to 50 mg protein, cleaved TIM9·10 was separated from uncleaved TIM9·10 on a Ni-NTA column using the above described protocol. The load and wash fractions were then further purified on a HiLoad 16/60 Superdex S200 pg, where TIM9·10 eluted as a single peak. For samples used in NMR experiments, gel filtration was performed with NMR buffer.

To purify the individual subunits of the TIM9·10 complex, an additional washing step was included into the Ni-NTA purification protocol: after washing with buffer B, the column was washed with 10 CV of buffer B supplemented with 3 M guanidine-HCl to dissociate the TIM9·10 complex. While His-tagged Tim10 was still bound to the Ni-NTA column, Tim9 was found only in the wash fraction. His-Tagged Tim10 was eluted with buffer C supplemented with 3 M guanidine-HCl and refolded by flash dilution into buffer A, the His-tag was cleaved as described above. The wash fraction including Tim9 was dialyzed into buffer A and both (Tim9 and Tim10) subjected to gel filtration on a HiLoad 16/600 75 PG. Tim9 was found to elute as a dimer, Tim10 mainly as a monomer.

### Expression and purification of TIM9·10 substrates Ggc1, Ggc1-C222S, Ggc1-C222S/C8Q, Aac3 and Aac3(2TM) {#sec4.4.4}

*Saccharomyces cerevisiae GGC1* constructs were purchased from GeneCust in pET21b, Aac3 constructs in pET21a plasmids. Ggc1 constructs were designed with a C-terminal 6xHis-tag, Aac3(2TM) with a N-terminal 6xHis-Tag and Aac3 with a N-terminal 9xHis-Tag as shown above.

All TIM9·10 substrates were expressed in BL21(DE3) *E. coli* cells as inclusion bodies. Cells were grown at 37°C until an OD~600~ of 0.7 was reached and induced with 1 mM IPTG for 3 hr. The cell pellet was resuspended in buffer A, sonicated and centrifuged at 39121 x g for 30 min. The inclusion body pellet was resuspended in buffer A supplemented with 6 M guanidine-HCl (for scGgc1 wild-type 2 mM DTT were added to each purification step) and incubated at 4°C for 16 hr. The solubilized inclusion bodies were separated from the insoluble fraction by centrifugation and loaded on a Ni-NTA resin. Proteins were purified as described for TIM9·10 with addition of 3 M guanidine-HCl to all buffers.

### Isotope labeling {#sec4.4.5}

For NMR experiments TIM9·10 was expressed in D~2~O M9 minimal medium and either labeled with 1 g/L \[^15^N\] NH~4~Cl and 2 g/L D-\[^2^H,^13^C\] glucose or specifically labeled on alanine, leucine and valine side chains using the SLAM-A^β^ and DLAM-^LVproS^ kit from NMR-Bio (<http://www.nmr-bio.com>) according to the manufacturer's instructions. Accordingly, Ggc1-C222S was labeled on alanine and isoleucine side chains using the DLAM-A^β^/I^δ1^ kit from NMR-Bio.

### Site-specific spin-labeling of scGGC1 {#sec4.4.6}

Ggc1 containing one Cys residue (at position 8 or 222, see sequences above) was incubated for 1 hr at room temperature in 6 M guanidine-HCl with 10 mM DTT. Subsequently DTT was removed on an illustra NAP25 column and the protein was incubated with a three-fold molar excess of MTSL (1-oxyl-2,2,5,5-tetramethyl-Δ3-pyrroline-3-methyl)-methanethiosulfonate) dissolved in DMSO (dimethyl sulfoxide) for 16 hr at 4°C in the dark. Free MTSL was removed on an illustra NAP25 column. Efficiency of the spin labeling reaction was confirmed by continuous-wave electron paramagnetic resonance spectroscopy.

### Production of chaperone-precursor protein complexes {#sec4.4.7}

Purified inner-membrane protein (Aac3, Ggc1, Aac3(2TM)) in 6 M guanidine-HCl was bound to Ni-NTA resin and washed with 5 CV of 1 M guanidine-HCl. Subsequently, a twofold excess of TIM9·10 was added to the column in 1/5 of the CV. The flow-through containing TIM9·10 was collected, diluted 1:1 with buffer A and reloaded on the column. This step was repeated until 10 CV were reached and the guanidine-HCl concentration was below 0.05 M. The column was washed with another 5 CV of buffer A, the TIM9·10-substrate complex eluted with 5 CV of buffer C and dialyzed into buffer A or NMR buffer. We note that this approach was unsuccessful for producing complexes with outer-membrane precursor proteins, presumably because of the requirement for pre-formed β-hairpin structures, as demonstrated by the different binding behavior of linear and cyclic VDAC~257-279~ peptides.

### Cell-free expression of Ggc1 in the absence or presence of TIM9·10 {#sec4.4.8}

Ggc1 with a C-terminal HisTag in pIVEX 2.3d was expressed under cell-free conditions in batch mode for 2 h at 30°C, as described in [Table S3](#mmc3){ref-type="supplementary-material"} and in the caption of [Figure S1](#figs1){ref-type="fig"}A. In the presence of the TIM9·10 complex, aggregation of the nascent *in vitro* translated Ggc1 is prevented by formation of a soluble chaperone/precursor protein complex ([Figure S1](#figs1){ref-type="fig"}A).

### Analytical ultracentrifugation {#sec4.4.9}

Sedimentation velocity experiments were performed on the Biophysical Platform AUC-PAOL at IBS Grenoble, on an analytical ultracentrifuge XLI, with a rotor Anti-50 (Beckman Coulter, Palo Alto, USA) and double-sector cells of 12 mm and 1.5 mm optical path length equipped with Sapphire windows (Nanolytics, Potsdam, Germany).

Samples were measured in NMR buffer at 10°C at three different concentrations from 0.2 to 0.002 mM, and interference and absorption at 277 nm wavelength were recorded. The data were processed by Redate software v 0.2.1. The analysis was done with the SEDFIT software, version 14.7 g and Gussi 1.1.0a6.

### Circular dichroism spectroscopy {#sec4.4.10}

Far ultraviolet (FUV) CD spectra were recorded in a 1 mm cell at 0.1 mg/mL protein concentration at 35°C in buffer A on a Jasco J-810 spectropolarimeter continuously purged with nitrogen.

### NMR spectroscopy {#sec4.4.11}

All NMR experiments were performed on Bruker Avance III spectrometers equipped with cryogenically cooled TCI probeheads, operating at magnetic field strengths corresponding to ^1^H Larmor frequencies of 950, 850, 700 and 600 MHz, respectively. The sample temperature was set to 308 K, unless stated otherwise.

#### Sequence-specific resonance assignments of TIM9·10 {#sec4.4.11.1}

Assignment experiments were performed on TIM9·10 complexes with individually labeled subunits. To this end \[^2^H\]-labeled His-tagged Tim10 was mixed with a 1.2-fold excess of \[^2^H,^13^C,^15^N\]-labeled Tim9 and purified on a Ni-NTA column as described above. Unbound Tim9 was found in the wash fraction, while hexameric TIM\[^2^H,^13^C,^15^N\]9·\[^2^H\]10 was eluted. The His-tag was cleaved as described above and the complex subjected to gel filtration on a HiLoad 16/600 Superdex S200 PG in NMR buffer. To obtain TIM\[^2^H\]9\[^2^H,^13^C,^15^N\]10, the protocol was repeated with \[^2^H,^13^C,^15^N\] His-tagged Tim10 and \[^2^H\] Tim9.

The following experiments were recorded: 2D ^15^N-^1^H-BEST-TROSY HSQC, 3D BEST-TROSY HNCO, 3D BEST-TROSY HNcaCO, 3D BEST-TROSY HNCA, 3D BEST-TROSY HNcoCA, 3D BEST-TROSYHNcocaCB and 3D BEST-TROSY HNcaCB ([@bib20]).

Methyl groups Ala^β^, Leu^proS^ and Val^proS^ were assigned using 3D ^1^H-^1^H-NOESY-^13^C-HSQC and 4D ^15^N-HSQC-NOESY-^13^C-HSQC with 300ms mixing time. The assignment of the Ala^β\ 13^C resonance was independently confirmed from the HNCACB experiment.

Data were processed in NMRPipe ([@bib17]) and analyzed with CCPNMR ([@bib72]). Resonance assignments of backbone and ALV methyl sites were deposited in the BioMagResBank under accession number BMRB: 27052.

#### Diffusion ordered spectroscopy {#sec4.4.11.2}

Diffusion constants were derived from methyl-directed one-dimensional ^13^C filtered DOSY experiments ([@bib18]) performed at 600 MHz ^1^H Larmor frequency. All samples were measured at a concentration of 70 μM at 308 K in NMR buffer with 10% (v/v) D~2~O. Three samples were measured: ^13^CH~3~-ALV TIM9·10, ^13^CH~3~-ALV TIM9·10 in complex with unlabeled Ggc1 and unlabeled TIM9·10 in complex with ^13^CH~3~-AI Ggc1. Peak integrals were obtained from 1D integration over the methyl band.

#### Methyl order parameter measurements from relaxation-violated coherence transfer NMR {#sec4.4.11.3}

A triple-quantum based relaxation-violated coherence transfer experiment was performed to measure the fast methyl dynamics in TIM9·10 and in TIM9·10/Ggc1, i.e., the product of site-specific methyl-axis order parameter, *S*^2^, and the overall-tumbling correlation time constant, τ~c~. TIM9·10, labeled at ^13^CH~3~-ALV groups in an otherwise perdeuterated environment was either measured in the apo form or with bound Ggc1 (unlabeled), in D~2~O 20 mM MES-d~13~ 50 mM NaCl pD 6.1 (D~2~O NMR buffer). The experiments were recorded at a ^1^H Larmor frequency of 950 MHz, according to reference ([@bib65]). 12 different values of the 3Q relaxation delay (delay T in reference ([@bib65])) were acquired, from 1.1 to 35 ms. The ratio of peak integrals in the relaxation-violated coherence transfer (I~a~) and the reference experiment (I~b~) as a function of the relaxation delay T were fitted as described in the section '[Quantification And Statistical Analysis](#sec4.5){ref-type="sec"}'.

#### CPMG experiments {#sec4.4.11.4}

^1^H-^13^C multiple-quantum relaxation dispersion experiments ([@bib36]) were recorded to probe millisecond motion of methyl groups in TIM9·10, TIM9·10/Ggc1, TIM9·10/Aac3 and Ala^β^/Ile^δ1^ methyls in Ggc1 bound to TIM9·10. The samples were either ^13^CH~3~-ALV TIM9·10, or ^13^CH~3~-ALV-labeled TIM9·10 in complex with unlabeled Ggc1, or ^13^CH~3~-Ala^β^/Ile^δ1^-labeled Ggc1 bound to unlabeled TIM9·10. The CPMG relaxation period was set to 40 ms (TIM9·10 and TIM9·10/Ggc1) or 60 ms (TIM9·10/Aac3). The CPMG frequency applied for 40 ms was 0, 50, 100, 150, 200, 250, 300, 350, 400, 500, 600, 700, 800, 900 and 1000 Hz and for 60 ms 66, 133, 200, 267, 333, 400, 466, 533, 600, 733, 867, 1000 Hz. Additionally, a reference experiment with no CPMG relaxation period was performed and the effective relaxation rate constant R~2eff~ was obtained from the peak volumes in this reference experiment, I~0~, and the pek volumes in the CPMG experiment, I(ν~CPMG~), as R~2eff~ = −1/T·ln(I(ν~CPMG~) / I~0~). Experiments were performed at different static magnetic field strengths (600, 700, 850, 950 MHz), as stated in the caption of [Figure 6](#fig6){ref-type="fig"}D.

#### ^1^H intermolecular cross-relaxation experiments for measuring transferred NOEs {#sec4.4.11.5}

To detect the contact surface of Ggc1 with TIM9·10, we probed the effect of ^1^H spin saturation transfer, i.e., a NOE-type transfer, from unlabeled Ggc1 to a deuterated ^13^CH~3~-ALV-labeled TIM9·10. The principle of this measurement is identical to previously proposed HET-SOFAST experiments ([@bib59]), except that we apply this concept here to methyls, rather than backbone amides. The effect of saturation transfer, i.e., cross-relaxation from the protons of Ggc1 to TIM9·10, is monitored by measuring the intensity of TIM9·10 methyl peaks in two experiments. The first dataset (I~ref~) is a standard ^1^H-^13^C SOFAST experiment, using a recycle delay of 0.2 s. In a second experiment (I~sat~), an inversion pulse is applied at the beginning of the recycle delay, which inverts protons of Ggc1. If a given TIM9·10 methyl site is in close spatial proximity, the effective ^1^H longitudinal relaxation during the recycle delay will be slowed down in this latter experiment, because of the intermolecular cross-relaxation. The inversion pulse (ISNOB2 \[[@bib38]\]) was applied at 4 ppm with a band width of 2 ppm, i.e., in a spectral region that is devoid of TIM9·10 resonances, due to the \> 98% deuteration. The differential longitudinal relaxation of methyl ^1^H spins on TIM9·10 that arises from the intermolecular cross-relaxation can be monitored by the ratio of the intensities in the two experiments, I~sat~/I~ref~. To ensure that artifacts due to residual (\< 2%) protonation of TIM9·10 do not introduce bias, we recorded these experiments not only on ^13^CH~3~-ALV-TIM9·10 bound to unlabeled Ggc1, but also on ^13^CH~3~-ALV-TIM9·10 in the absence of Ggc1. In this latter experiment no inter-molecular cross-relaxation can occur. The values reported in [Figure 1](#fig1){ref-type="fig"}C have been corrected by the values obtained in this reference experiment.

In all cases, the samples were in D~2~O buffer, and the experiments were recorded at a ^1^H Larmor frequency of 950 MHz.

#### PRE experiments {#sec4.4.11.6}

A complex between ^13^CH^3^-ALV-TIM9·10 and MTSL-labeled Ggc1 containing a single Cys residue either at position 8 (Q8C) or 222 (wild-type) was prepared as described above. Methyl ^1^H R~1~ relaxation was measured for this TIM9·10/Ggc1~MTSL~ complex, and a sample in which the MTSL spin label was reduced by addition of 5 mM sodium ascorbate via a saturation-recovery experiment. Hereby, the recovery delay following the saturation element was incremented from zero to 3 s, and the site-specific buildup rate constants were fitted by a mono-exponential function. The effect of the paramagnetically tagged Ggc1 was monitored via the difference between R~1~ relaxation rate constants between the paramagnetic and the ascorbate-reduced sample.

#### NMR-based measurement of precursor protein transfer kinetics between chaperones {#sec4.4.11.7}

To probe at which rate precursor protein is transferred between TIM9·10 chaperones, we have prepared a complex of unlabeled TIM9·10 with ^2^H,^15^N-labeled Aac3(2TM), and concentrated to 300 μM in NMR buffer. The ^15^N-labeling of the precursor protein allows verifying the state of the precursor protein. 60 μL of this solution were mixed with 100 μL of ^2^H, ALV-methyl labeled TIM9·10 at a concentration of 160 μM, resulting in concentrations of 100 μM ALV-TIM9·10, 112 μM Aac3(2TM) and 112 μM unlabeled TIM9·10. The dead time between mixing of the solutions and acquisition of the first NMR spectrum was 5 min.

The intensity of the methyl resonances was followed through a series of ^1^H,^13^C SOFAST-HMQC experiments. The number of scans was varied from 2 (to capture the initial phase of the decay; duration of one 2D experiment: 3 min 50 s) to 64 for the last data points for enhanced signal-to-noise ratio (duration of one 2D experiment: 2 hr). The peak intensities from well-resolved cross-peaks of residues in the binding cleft or at the top of the TIM9·10 structure, outside the binding cleft, were determined in CCPNMR, and exported for fitting with in-house written Python scripts. Monoexponential fits of the intensity decays of individual peaks in the binding cleft revealed similar kinetic rate constants, as expected for the global process in which apo TIM is converted to precursor-protein-loaded TIM. To increase signal-to-noise ratio, peak intensities of residues in the binding cleft and at the top of the chaperone were added up as indicated in [Figure 6](#fig6){ref-type="fig"}H.

The fact that residues outside the binding cleft show near-constant intensity allows us to exclude that the sensitivity drop observed for binding cleft residues is due to, e.g., precipitation of the protein.

The expected intensity plateau level after equilibration of the reaction, relative to the initial intensity is, thus, given by the ratio of intensities observed in (equilibrium) holo and apo samples (I~holo~/I~apo~; [Figure S1](#figs1){ref-type="fig"}G) and the respective concentrations of labeled and unlabeled TIM in the mixed sample (\[TIM~lab~\], \[TIM~unlab~\]), as I~plateau~ = ((I~holo~/I~apo~^∗^\[TIM~lab~\]) + (1^∗^\[TIM~unlab~\])) / (\[TIM~lab~\]+ \[TIMun~lab~\]). For example, for a residue with a I~holo~/I~apo~ ratio of 0.5 and the concentrations used in the mixed sample according to our experiment (see above), the plateau level is expected at 0.76.

The experiment was repeated twice with independent samples, resulting in similar exchange kinetic rate constants (not shown).

### VDAC peptide titration {#sec4.4.12}

VDAC peptides were chemically synthesized as described elsewhere ([@bib31]), lyophilized, and dissolved in DMSO. The DMSO concentration was reduced by stepwise addition of NMR buffer (1:1 in each step). At a DMSO concentration of 10% (v/v), TIM9·10 in NMR buffer was added instead of pure NMR buffer to yield a final DMSO concentration of 6% and a TIM9·10 concentration of 0.15 mM. NMR intensities and peak positions of the LV-^13^CH~3~ groups and amide backbone sites of TIM9·10 were obtained from 2D ^1^H-^13^C HMQC and ^1^H-^15^N HSQC experiments, using samples containing VDAC peptides at molar ratios of 1:0 to 1:4, as shown in [Figures 2](#fig2){ref-type="fig"}B and 2C and [S2](#figs2){ref-type="fig"}. In all cases, the DMSO concentration was kept to 6% to ensure comparability.

### Cross-linking of VDAC peptides to TIM9·10 {#sec4.4.13}

Synthesis of the Bpa-containing linear and cyclic β-hairpin peptides was described before ([@bib31]). *In vitro* photo-crosslinking was performed by mixing the purified TIM9·10 complex (5 μM) with Bpa-containing β-hairpin peptides at concentrations of 25 μM or 50 μM, as indicated in the [Figure 2](#fig2){ref-type="fig"}A, in crosslinking buffer (20 mM HEPES, 100 mM NaCl, 1.5 mM MgCl~2~, pH 7.25). The mixture was incubated for 10 min on ice before UV-irradiation for 30 min at 4°C using a Blak-Ray B-100 AP UV lamp at a distance of 10 cm from the samples. After UV-illumination, the samples were mixed with 4x Laemmli buffer, incubated at 95°C for 5 min and analyzed by SDS-PAGE and silver staining.

### Small-angle X-ray scattering data collection and analysis {#sec4.4.14}

SAXS data were collected at ESRF BM29 beam line ([@bib50]) with a Pilatus 1M detector (Dectris) at the distance of 2.872 m from the 1.8 mm diameter flow-through capillary. Data on TIM9·10 were collected in a batch mode. The scattering of pure water was used to calibrate the intensity to absolute units. The X-ray energy was 12.5 keV and the accessible q-range 0.032 nm^-1^ to 4.9 nm^-1^. The incoming flux at the sample position was in the order of 10^12^ photons/s in 700x700 μm^2^. All images were automatically azimuthally averaged with pyFAI ([@bib2]). SAXS data of pure TIM9·10 was collected at 1, 2.5 and 5 mg/mL using the BioSAXS sample changer ([@bib56]). Ten frames of 1 s were collected for each concentration. Exposures with radiation damage were discarded, the remaining frames averaged and the background was subtracted by an online processing pipeline ([@bib9]). Data from the three concentrations were merged following standard procedures to create an idealized scattering curve of TIM9·10, using Primus from the ATSAS package ([@bib51]). The pair distribution function p(r) was calculated using GNOM ([@bib66]).

Online purification of the TIM9·10/Ggc1 complex using a NiNTA column was performed with a high pressure liquid chromatography (HPLC) system (Shimadzu, France), as described in reference ([@bib10]). The HPLC system was directly coupled to the flow-through capillary of SAXS exposure unit. The buffer used in this experiment was Buffer A. The flow rate for all online experiments was 0.2 mL/min. Data collection was performed continuously throughout the chromatography run at a frame rate of 1 Hz. The stoichiometry of the individual peaks in the chromatogram was determined from molecular mass estimates based on the correlated and Porod volumes ([@bib51]) and by calculating the ratios of maximum forward scattering and maximum absorbance at 280 nm for each peak and comparing to the theoretical values of different stoichiometries. For creating background corrected scattering curves for the TIM9·10:Ggc1 2:1 complex peak, measurements of buffer with the lowest (200 mM) and the highest (300 mM) possible imidazole concentration, as well as interpolated curves between these two extremes, were subtracted individually from each frame. The resulting curves were independent of protein concentration, as shown with procedures outlined by [@bib29]. Subtraction of the highest imidazole concentration provided a stable signal throughout the center of the peak. 50 frames from the middle of the peak were averaged to create a single SAXS curve for the TIM9·10:Ggc1 2:1 complex. For all subsequent analyses, the robustness of the main findings (general shape and dimensions) was confirmed by analogous treatment of curve resulting from the subtraction of the lowest possible imidazole concentration. The pair distribution function p(r) was calculated using GNOM. SAXS data along with their MD-derived models (described below) are shown in [Figure S6](#figs6){ref-type="fig"} and the experimental and fit parameters are reported in [Table S4](#mmc4){ref-type="supplementary-material"}. SAXS data reported in this study have been deposited in the SASBDB data bank (<https://www.sasbdb.org>) with accession numbers SASDEF2 (TIM9·10) and SASDEG2 (TIM9·10/Ggc1).

### Molecular dynamics simulations {#sec4.4.15}

#### (a) All-atom MD simulation of apo-TIM9·10 {#sec4.4.15.1}

We used the crystal structure (PDB ID [3DXR](pdb:3DXR){#intref0110} \[[@bib77]\]) as the initial model of the TIM9·10 hexamer. Missing residues were added using MODELLER9.18 ([@bib76]). The protein was solvated in a cubic box of TIP3P water molecules with sides of 10.6 nm and periodic boundary conditions. The Amber ff99SB^∗^-ILDN force field ([@bib41]) was used for the simulations. The temperature and pressure were kept constant at 298 K using the v-rescale thermostat with a 1 ps coupling constant and at 1.0 bar using the Parrinello-Rahman barostat with a 2 ps time coupling constant, respectively. We employed the virtual sites for hydrogen atoms with a single LINCS iteration (expansion order 6) and constrained the bonds involving hydrogen atoms using the LINCS algorithm, allowing simulations to be performed with an integration time step of 5 fs. The long-range electrostatic interactions were calculated by the means of the particle mesh Ewald decomposition algorithm with a 0.16 nm mesh spacing. A one-microsecond MD simulation was performed to collect the conformations of the apo TIM9·10 hexamer for further SAXS guided ensemble refinement using a maximum entropy method as described in the following section. The all-atom simulation revealed the upper part of the α helices of the TIM9·10 hexamer are rigid, and are increasingly flexible toward their extremities, i.e., toward the N- and C-termini of the subunits ([Figure S5](#figs5){ref-type="fig"}B).

#### (b) Coarse-grained MD simulations of the TIM9·10/Ggc1 complex {#sec4.4.15.2}

To enhance the sampling of the TIM9·10/Ggc1 complex, we employed a simplified model in which each residue is coarse-grained into two beads (except glycines) to represent the backbone and side chain, respectively. One bead (C~A~) is located at the position of the C~α~ atom. The other bead (C~B~) is located at the center of mass of the side chain atoms. The basic idea was to combine a structure-based model for the folded chaperone with a more transferable model, which also includes non-native hydrophobic and electrostatic forces, to describe the interactions between the chaperone and carrier protein, and within the carrier protein. More specifically, the energy function of the coarse-grained model can be expressed by:$$V_{CG}=V_{SB}+V_{charge}+V_{hydrophobic}+V_{restraints},$$where V~SB~ is the structure-based potential to describe the local dynamics of the TIM9·10 hexamers around its crystal structure (PDB ID [3DXR](pdb:3DXR){#intref0115}). The V~SB~ term can be divided into local (bonded) and non-local terms. The non-local part of V~SB~ can be further partitioned into two components consisting of an attractive term, which is a function of the native contact map to stabilize the secondary and tertiary structures, and a repulsive term to provide the excluded volume. A detailed description of V~SB~ can be found in ref. ([@bib13], [@bib74]). V~charge~ and V~hydrophobic~ are the electrostatic and hydrophobic potential, respectively, to describe the non-native interactions between TIM hexamers and Ggc1. V~charge~ is represented by the Debye-Hückel model ([@bib74]) which is a linearization of the Poisson-Boltzmann equation. The charge states of C~B~ beads were assigned according to their possible electrostatic properties at neutral pH (1.0 for Lys and Arg, −1.0 for Asp and Glu and 0.5 for His in our model). V~hydrophobic~ is expressed by:$$V_{hydrophobic} = \varepsilon_{HP}\sum\limits_{i}{\sum\limits_{j}{- K_{ij}e^{- 0.5{({R_{ij} - D_{HP}})}^{2}}}}$$where *R*~*ij*~ is the distance between C~B~ beads *i* and *j, D*~*HP*~ is the optimal distance to form interfacial hydrophobic interactions, and *K*~*ij*~ is the strength of the hydrophobic interaction between C~B~ beads i and j. The *K*~*ij*~ matrix (in units of kJ mol^-1^) is transformed from the original Miyazawa-Jernigan matrix ([@bib45]). We set ε~HP~ = 0.92 and D~HP~ = 5.0 Å which have been calibrated by [@bib75] for eight di-ubiquitin systems.

We supplemented the model outlined above with information from NMR on the site where TIM binds to Ggc1. In particular, we constructed a non-specific potential term that encourages Ggc1 to form contacts with those residues on TIM that were found by NMR to interact with the carrier proteins. This was achieved by adding an energy term, V~restraints~, which is a half-harmonic potential of the form of V~restraints~ = k(Q − Q~ref~)^2^ when the value of Q is lower than a certain limit Q~ref~, and zero when Q \> Q~ref~. Here Q is the coordination number to define the sidechain contacts between Ggc1 and the binding site of TIM9·10 (M21, F24, L27, Y28 and F74 for TIM9, and L26, L28, V29, M32, F33, M80 for TIM10). We used Q~ref~ = 28 and k = 20kJ mol^-1^.

MD simulations were performed with GROMACS 5.1.4 ([@bib1]) at temperature T = 60 (in reduced units) combined with the PLUMED 2.3 plugin ([@bib67]). A time step of 0.5 fs was used and the simulation was coupled to a temperature bath via Langevin dynamics with a coupling time of 1.0. We performed sixteen MD simulations of the TIM/Ggc1 complex starting from eight different initial conformations ([Figure S6](#figs6){ref-type="fig"}E) which were modeled manually using PyMol and energy minimized by the steepest descent algorithm. 14 million MD time steps (7 ns) were performed for each of the 16 trajectories, resulting in a total of 112 ns. Note that the actual timescale sampled is orders of magnitude longer, due to the enhanced sampling afforded by the coarse-graining and simplified energy function employed.

### Workflow of the ensemble refinement using SAXS data {#sec4.4.16}

1)First, we collected the conformational pools of the apo TIM hexamer and the TIM9·10/ Ggc1 complex as large as possible by MD simulations with all-atom or coarse-grained models (see above). For the TIM9·10/Ggc1 complex, the atomistic structures were reconstructed from the C~α~ coordinates of the coarse-grained trajectories using PULCHRA ([@bib55]).2)We back-calculated the SAXS curve of each frame using Crysol3 ([@bib21]). For a few frames we also compared with FoxS ([@bib61]) (like Crysol uses a fast but implicit description of the hydration layer) and WAXSiS ([@bib33]) (slower but with an explicit model for both the hydration layer and the excluded solvent), and found that the SAXS calculation by Crysol3 matched rather closely those from WAXSiS (data not shown), but with the computational cost as low as FoxS. Accordingly, we used Crysol3 in this work to balance the accuracy and computational cost.3)We employed the maximum entropy approach ([@bib8], [@bib28]) to refine the simulated ensembles so as to match experimental SAXS data. Briefly, the ensemble refinement method attempts to adjust the prior conformational weights of frame *j* $\left( \omega_{j}^{0}\rightarrow\omega_{j} \right)$ so as to minimize the target 'free-energy-like' function$$F\left( \omega_{j} \right) = \frac{M}{2}\chi^{2} - \theta S_{rel}$$where$$\chi^{2} = \frac{1}{M}\sum_{i}^{M}\frac{\left( {\sum_{j}^{N}{w_{j}I_{i}^{calc}\left( x_{j} \right)} - I_{i}^{\mathit{\exp}}} \right)^{2}}{\sigma_{i}^{2}}$$measures the deviation from the experimental averages, *M* is the number of data points in the scattering profile, $I_{i}^{calc}\left( x_{j} \right)$ is the intensity back-calculated from the atomic coordinates of frame *j* (*x*~*j*~), *N* is the number of conformers used for back-calculating the average scattering data, and $S_{rel} = - \sum_{j}^{N}{\omega_{j}\text{ln}\left( {\omega_{j}/\omega_{j}^{0}} \right)}$ is the Kullback-Leibler divergence (relative entropy) which measures the deviation from the prior uniform distribution $\omega_{j}^{0} = {1/N}$. In this work, we sampled 1,000 conformers (N = 1,000, with one snapshot per ns) for the apo TIM and ∼70,000 conformers (N = 70,000) for the holo TIM9·10/Ggc1 complex. In the Maximum Entropy/Bayesian formalism, θ is a free 'temperature-like' parameter to control the relative contribution of *χ*^*2*^ and *S*~*rel*~ terms. For large θ, the ensemble refinement algorithm leads to small perturbations of the initial weights (small Kullback-Leibler divergence), whereas for small θ, it is possible to change the weights substantially to obtain the best possible agreement with the experimental scattering data, but possibly have the risk of over-fitting. One may find an appropriate choice of θ by inspecting the relative entropy S~rel~ against the χ^2^ obtained in reweighting for different values of θ ([Figures S6](#figs6){ref-type="fig"}F--S6I): as θ is lowered one gradually obtains an improved fit, but at the smallest values of θ one only obtains marginal improvements in fit quality at the cost of a substantial loss of entropy (i.e., a large deviation from the molecular dynamics ensemble). The software to perform the ensemble refinement is available from <https://github.com/sbottaro/bme>, and we used the back-calculated scattering data for apo TIM (θ = 729) and the TIM9·10/Ggc1 complex (θ = 1369) ([Figures S6](#figs6){ref-type="fig"}F--S6I). The comparison of the final results with experimental scattering data is shown in [Figures S6](#figs6){ref-type="fig"}A--S6D.4)Lastly, to provide a simpler way for visualizing the ensembles, we reconstructed a sub-ensemble by randomly picking 1,000 frames with individual probabilities proportional to their reweighting weights in the conformational pool. These conformations were then clustered ([@bib15]) with an RMSD cut-off of 0.8 nm after aligning the structure by the position of two TIM hexamers. We repeated the reconstruction process three times, and all resulted in similar sub-ensembles. The top twelve clusters occupy ∼80% of the conformational space of the sub-ensemble, as illustrated in [Figure 7](#fig7){ref-type="fig"}E.

### Yeast handling and growth conditions {#sec4.4.17}

Since *TIM9* and *TIM10* are essential genes, *tim9* and *tim10* mutants were introduced into *Saccharomyces cerevisiae* by plasmid shuffling, to exchange *TIM9* or *TIM10* wild-type with the mutated version of *tim9* or *tim10* in a YPH499 background. Shuffle strains for Tim9 and Tim10 were used, harboring the genomic deletion of *TIM9* or *TIM10* complemented by the *URA3* selectable plasmid, YEp352, containing the *TIM9* or *TIM10* wild-type gene. To study the defects in *tim9* and *tim10* mutants in the absence of the homologous complex Tim8-Tim13, shuffle strains lacking *TIM8* and *TIM13* in addition to the genomic deletion of *TIM9* or *TIM10* were transformed (*tim9*Δ *tim8tim13*ΔΔ + YEp352-Tim9 or *tim10*Δ *tim8tim13*ΔΔ + YEp352-Tim10). The genomic deletion of *TIM8* and *TIM13* was introduced by homologous recombination according to the protocol of [@bib30]. According to the protocol, PCR cassettes were amplified from genomic DNA with S1 and S2 primers, containing the antibiotic resistance for nourseothricin (*natNT2*) (Tim8) or hygromycin (*hphNT1*) (Tim13) flanked by homologous regions up- and downstream of the target gene. The chromosomal integration of the amplified cassettes led finally to the deletion of *TIM8* and *TIM13* (*tim9*Δ *tim8tim13*ΔΔ + YEp352-Tim9 or *tim10*Δ *tim8tim13*ΔΔ + YEp352-Tim10), which was verified by colony PCR.

Centromeric pFL39 plasmids with the yeast selectable marker *TRP1*, encoding the *tim9* or *tim10* mutants under the control of the endogenous promoter and terminator (pFL39-*tim9* or pFL39-*tim10*), were transformed into the shuffle strains by the lithium acetate method of Gietz and Woods. After *TRP1* selection (0.67% \[w/v\] yeast nitrogen base without amino acids (Becton Dickinson), 3% \[w/v\] agar (Becton Dickinson), 0.077% \[w/v\] SC amino acids without tryptophan (-TRP) (MP Biomedicals), 2% \[v/v\] glucose (Roth)), yeast clones were selected on 5FOA (5-Fluoroorotic acid) containing agar medium (0.065% \[w/v\] yeast nitrogen base without amino acids (Becton Dickinson), 3% \[w/v\] agar (Becton Dickinson), 0.077% \[w/v\] SC amino acids without uracil (-URA) (MP Biomedicals), 2% \[w/v\] glucose (Roth), 0.005% \[w/v\] uracil (Fluka Analytical), 0.065% \[w/v\] 5FOA (Melford)), selecting for clones, which lost the *URA3* plasmid YEp352 encoding wild-type *TIM9* or *TIM10*. Finally, clones were streaked on YPG medium (1% \[w/v\] yeast extract (Becton Dickinson), 2% \[w/v\] bacto peptone (Becton Dickinson), 3% \[w/v\] glycerol (Sigma), 3% \[w/v\] agar (Becton Dickinson)) to exclude the loss of mitochondrial DNA. During all transformation steps, cells were incubated at 23°C to minimize temperature sensitive growth phenotypes. Mutations, which did not give rise to at least two viable colonies after three rounds of plasmid shuffling were considered lethal.

To study the growth phenotype of the mutants, 4 mL YPG medium were inoculated with yeast and grown over night at 23°C and shaking at 130 rpm. Yeast cells corresponding to an OD~600~ of 1 were centrifuged for 5 min at 1,500 x g (4,000 rpm, Eppendorf 5424). The cell pellet was taken up in 1 mL sterile dH~2~O and 3 μl of a serial yeast dilution (1:10, 1:100, 1:1,000, 1:10,000) were dropped on YPD (1% \[w/v\] yeast extract, 2% \[w/v\] bacto peptone, 2% \[v/v\] glucose (Roth), 3% \[w/v\] agar (Becton Dickinson)) and YPG media. After incubation at the indicated temperatures the growth plates were photographed and non-relevant growth plate areas were excised digitally indicated by a small gap.

### Isolation of mitochondria {#sec4.4.18}

Yeast cells were grown in YPG medium at permissive temperature (19-23°C) and shaking with 130 rpm as a preculture. The main yeast culture was inoculated with the preculture and grown under permissive conditions (19-23°C) for 24 hr and shaking at 130 rpm. Yeast cells were harvested in an exponential growth phase at 1,700 x g (4,000 rpm, H-12000, Thermo-Fisher Scientific) for 10 min at room temperature (RT). Cell pellet was resuspended and washed in dH~2~O and centrifuged for 5 min at RT and 1,500 x g (3,000 rpm, SLA-3000, Sorvall). Yeast cells were incubated in 2 ml/g wet weight DTT buffer (100 mM Tris(hydroxymethyl)aminomethane (Tris)/H~2~SO~4~ (MP Biomedicals and Roth), pH 9.4, 10 mM dithiothreitol (DTT, Roth)) for 30 min at 130 rpm and 23°C. Cells were reisolated for 5 min at 2,000 x g (3,500 rpm, SLA-3000, Sorvall) and washed once in sorbitol buffer (16 mM K~2~HPO~4~ (Roth), 4 mM KH~2~PO~4~ (Roth), pH 7.4, 1.2 M sorbitol (Roth)). The cell suspension was then treated for 45 min in 6.5 ml/g wet weight sorbitol buffer including 4 mg/ml Zymolyase 20T (Nacalai Tesque, Inc.) at 23°C and 130 rpm. Spheroplasts were isolated and washed once in sorbitol buffer for 5 min at 1,500 x g (3,000 rpm, SLA-3000, Sorvall). The pellet was resuspended in homogenization buffer (0.6 M sorbitol, 10 mM Tris/HCl, pH 7.4, 1 mM ethylenediaminetetraaceticacid (EDTA, Calbiochem), 0.4% \[w/v\] bovine serum albumin (ChemCruz), 1 mM phenylmethyl sulfonyl fluoride (PMSF, Sigma)) and spheroplasts were mechanically opened on ice by homogenizing 20 times in a glass-Teflon potter. Mitochondria were isolated by differential centrifugation. Cell debris were removed by spinning 2 min 260 x g (1,500 rpm, SA800, Sorvall) followed by 4 min at 1,000 x g (3,000 rpm, SA800, Sorvall) and 4°C. The supernatant was transferred in a fresh tube and spun for 15 min at 1,870 x g (4,000 rpm, SA800, Sorvall). To pellet mitochondria, supernatant was spun for 15 min at 16,800 x g (12,000 rpm, SA800, Sorvall) and 4°C. The mitochondrial pellet was washed in ice cold SEM buffer (250 mM sucrose (MP Biomedicals), 10 mM 3-(*N*-morpholino)propanesulfonic acid (MOPS, Sigma), pH 7.2, 1 mM EDTA) and spun 5 min at 1,870 x g (4,000 rpm, SA800, Sorvall) and 4°C. Supernatant was transferred into a fresh tube and mitochondria were reisolated for 15 min at 16,800 x g (12,000 rpm, SA800, Sorvall) and 4°C. Finally, the mitochondrial pellet was taken up in a small volume of ice cold SEM buffer and the protein concentration was determined by employing the Bradford assay. Mitochondria at 5-10 μg/ml SEM were snap frozen in liquid nitrogen and stored at −80°C.

### Site-directed mutagenesis {#sec4.4.19}

Single amino acid substitutions in Tim9 and Tim10 were introduced by site-directed mutagenesis. The centromeric plasmid pFL39 containing the open reading frame of *Saccharomyces cerevisiae TIM9* or *TIM10* under the control of their endogenous promoter and terminator (see [Key Resources Table](#sec4.1){ref-type="sec"}) was used as template for a PCR amplification with Q5 polymerase (NEB) and primers encoding the desired mutation ([Table S2](#mmc2){ref-type="supplementary-material"}). After template digest (3 hr, 37°C) with DpnI (NEB), the PCR products were transformed into XL-1 Blue *Escherichia coli* cells (Stratagene). Plasmids of single colonies were isolated by using the QIAprep Spin Miniprep Kit (QIAGENe) and verified by sequencing.

### Gel electrophoresis and western blotting {#sec4.4.20}

For SDS-PAGE analysis, mitochondria were pelleted (5 min, 20,800 x g, 4°C (14,000 rpm, Eppendorf 5417R)) and resuspended in Laemmli buffer (60 mM Tris, pH 6.8, 2% \[w/v\] dodecylsulfate-Na-salt (SDS (Serva)), 10% \[v/v\] glycerol, 0.02% \[w/v\] bromphenol blue (Sigma)) containing 2 mM PMSF and 2% \[v/v\] 2-mercaptoethanol and incubated for 5-15 min at 65-95°C at 1,400 rpm. Laemmli samples were either loaded to 15% polyacrylamide gels containing 15% polyacrylamid (Rotiphorese Gel 30 (30% acrylamide, 0.8% bisacrylamide) (Roth)) and run in SDS running buffer (25 mM Tris/HCl, pH 8.8, 191 mM glycine (MP Biomedicals), 1% \[w/v\] SDS) at 35 mA for 2.5 h or 10% Tris-Tricine polyacrylamide gels containing 10% polyacrylamide (49.5% \[w/v\] acrylamide (Roth), 3% \[w/v\] bisacrylamide (Serva)) and run in anode (0.2 M Tris/HCl, pH 8.9) and cathode (0.1 M Tris, 0.1 M tricine (Roth), 0.1% \[w/v\] SDS, pH 8.25) buffer at 65-80 mA, 600 V for 3-4 h. Afterward, proteins were transferred by standard semi-dry western blot transfer on PVDF membranes (Immobilon-P (Millipore)) at 25 V, 250 mA for 2.5 h in Western transfer buffer (20 mM Tris, 150 mM glycine, 0.02% \[w/v\] SDS, 20% \[v/v\] methanol). Prior to antibody decoration, equal loading on the membranes was checked by protein staining (0.2% Coomassie R250 (Roth), 10% \[v/v\] acetic acid (Roth) and 30% \[v/v\] ethanol), membranes were destained in 100% methanol, shortly washed in TBST (200 mM Tris/HCl, pH 7.5, 1.25 M CaCl~2~ (Roth), 0.1% Tween20 (Sigma)) and then incubated for 1 h in 5% \[w/v\] fat-free dried milk powder (Frema Reform) in TBST at room temperature. Then membranes were incubated for 3 h in the indicated primary antibodies (see [Key Resources Table](#sec4.1){ref-type="sec"}) and 1 h in secondary anti-rabbit IgG antibody (Sigma), diluted 1:10,000 in 5% \[w/v\] fat-free dried milk powder in TBST. Before and after each antibody decoration, membranes were washed in three 5 min washing steps in TBST. Finally, membranes were incubated in ECL solution ([@bib22]) and the resulting chemiluminescence signals were detected by a LAS-4000 camera system (Fujifilm).

For blue native PAGE analysis, mitochondria were solubilized for 15 min on ice in digitonin buffer (0.1 mM EDTA, 10% \[v/v\] glycerol, 50 mM NaCl (Roth), 1 mM PMSF, 20 mM Tris/HCl, pH 7.4, 0.35 - 1% \[w/v\] digitonin (MATRIX BioScience). Prior loading of the supernatant to a 4-6.5 to 16% discontinuous gradient gel, blue native loading dye (0.5% \[w/v\] Coomassie blue G (Serva), 50 mM 6-aminocaproic acid (Sigma), 10 mM Bis/Tris (Roth), pH 7) was added. Gel electrophoresis was performed in anode (50 mM Bis/Tris/HCl, pH 7) and cathode buffer (50 mM tricine, pH 7, 15 mM Bis/Tris, 0.02% \[w/v\] Coomassie G) at 600 V, 15-20 mA/gel for 1.5 - 3.5 h at 4°C. After gel electrophoresis, gels were destained and fixed (50% \[v/v\] ethanol, 10% \[v/v\] acetic acid) until protein bands became visible.

Gels were dried and exposed to PhosphorImager screens (GE Healtcare and Fuji) and signals were detected with a FLA7000 scanner (GE Healthcare). Non-relevant gel lanes were excised digitally, as indicated by a small gap. For radioactive SDS samples, gels were first stained (30% \[v/v\] ethanol, 10% \[v/v\] acetic acid, 1% \[w/v\] Coomassie R250) and destained to compare equal protein loading and then dried and exposed.

### *In vitro* transcription and translation {#sec4.4.21}

For *in vitro* translation of ^35^S-radiolabeled precursor proteins, plasmids carrying a SP6 promoter-binding region followed by the gene of interest were used. Plasmids were incubated with the TNT SP6 quick coupled kit (Promega), an *in vitro* eukaryotic transcription/translation system based on rabbit reticulocytes, and \[^35^S\] methionine (PerkinElmer) for 2 hr at 30°C and 300 rpm.

For the *in vitro* translation of \[^35^S\]Por1 the Rabbit Reticulocyte Lysate System (Promega) was used. First, mRNA was synthesized by using the mMESSAGE mMACHINE SP6 kit (Invitrogen) and cleaned up by the MEGAclear Transcription Clean-Up kit (Invitrogen). Radiolabeled proteins were translated by using the Rabbit Reticulocyte Lysate System (Promega) for 2 hr at 30°C and 300 rpm.

After translation, 20 mM unlabeled methionine (Roth) and 0.3 M sucrose (MP Biomedicals) were added. Lysate was snap frozen in liquid nitrogen and stored at −80°C.

### *In vitro* import into mitochondria {#sec4.4.22}

Radiolabeled precursor proteins were imported into 50 μg mitochondria per reaction (protein amount) in the presence of 100 μl import buffer (3% \[w/v\] bovine serum albumin (Sigma), 250 mM sucrose, 80 mM KCl (Roth), 5 mM MgCl~2~, 2 mM KH~2~PO~4~, 5 mM methionine (Sigma), 10 mM MOPS-KOH (Roth), pH 7.2) with 4 mM ATP (Roche), 4 mM NADH (Roth), 2 mM creatine phosphate (Roche) and 2 mM creatine kinase (Roche). To deplete the membrane potential (-Δψ), AVO mix (8 μM antimycin A (Sigma), 1 μM valinomycin (Sigma), 20 μM oligomycin (Sigma), final concentrations) was added and NADH was excluded ([@bib64]). Finally, 2 to 10% \[v/v\] of rabbit reticulocyte lysate was added and the import reaction was incubated at 25°C and 300 rpm for indicated time periods. Membrane potential dependent import reactions were stopped with 1 μl AVO mix and transferred on ice. For precursors imported into the mitochondrial matrix or inner membrane, not imported precursor proteins were digested by Proteinase K treatment (22.7 mg/ml; Roche) for 15 min on ice and protease activity was inhibited by addition of 1.78 mM (f.c.) PMSF before mitochondria were reisolated for 5 min at 20,800 x g (14,000 rpm, Eppendorf 5417R) at 4°C. Mitochondria were washed with 100 μl ice cold SEM buffer. Finally, mitochondria were either resuspended in Laemmli buffer (0.2 M Tris, pH 6.8, 2% \[w/v\] SDS, 4% \[v/v\] glycerol, 12.5% \[w/v\] bromphenol blue, 1 mM PMSF) or solubilized in digitonin buffer (20 mM Tris/HCl, pH 7.4, 0.1 mM EDTA, 50 mM NaCl, 10% \[v/v\] glycerol, 0.35%--1.75% digitonin), to be analyzed either on SDS-PAGE or blue native PAGE.

For analysis of carrier precursor binding by TIM9·10 complex by a precursor arrest at the translocase of the outer mitochondrial membrane (TOM), the radiolabeled carboxyl-terminal fusion protein of Aac2 and DHFR (dihydrofolate reductase) was imported according to [@bib57].

### Membrane potential assessment {#sec4.4.23}

The membrane potential (Δψ) of isolated mitochondria was assessed by fluorescence quenching using the luminescence spectrometer Aminco Bowman II (Thermo Electron Corporation). Mitochondria were incubated in 3 mL potential buffer (0.6 M Sorbitol, 0.1% \[w/v\] BSA, 10 mM MgCl~2~, 0.5 mM EDTA, 16 mM K~2~HPO~4~, 4 mM KH~2~PO~4~, pH 7.4) in the presence of 5 mM L-malate (Sigma), 5 mM succinate (Sigma) and 3 μl DiSC3 (3,3′-dipropylthiadicarbocyanine iodide (Invitrogen)). Absorption was measured by an excitation of 622 nm and an emission of 670 nm until the distribution equilibrium was reached and 3 μl 1 mM valinomycin were added to dissipate the membrane potential.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### General considerations about quantitative analysis of NMR data {#sec4.5.1}

Quantitative NMR data, such as HETSOFAST data, CPMG relaxation dispersion or relaxation data have been based on analyses of peak integrals, determined in CCPNMR ([@bib72]), and subsequent analyses in in-house written python scripts, unless stated otherwise. Generally, error margins on peak integrals have been determined from the spectral noise (generally 3 times the standard deviation of spectral noise was used), and Monte Carlo analysis of the fit data.

### Diffusion ordered NMR spectroscopy {#sec4.5.2}

Diffusion coefficients were obtained from a series of methyl-detected DOSY NMR experiments. The integrated intensity as a function of the gradient strength was used to fit the diffusion coefficient (D) using the following equation:$${I=}I_{0}{\cdot exp}\left( {- D \cdot \gamma_{Η}^{2} \cdot g^{2} \cdot \delta^{2} \cdot \left( {D - {\delta/3} - {\tau/2}} \right)} \right),$$where I is the peak integral, γ~H~ is the gyromagnetic ratio of protons, g is the gradient strength in Gauss/cm, and Δ, δ and τ are delays in the pulse sequence as described in [@bib18].

### Methyl order parameter measurements from relaxation-violated coherence transfer NMR {#sec4.5.3}

Order parameters of methyl axes were obtained from triple-quantum relaxation experiments. The ratio of peak integrals in the relaxation-violated coherence transfer (I~a~) and the reference experiment (I~b~) as a function of the relaxation delay T were fitted according to Equation 7 of [@bib65]:$$\frac{I_{a}}{I_{b}} = \frac{3}{4}\frac{\eta\ \tanh\left( {\sqrt{\eta^{2} + \delta^{2}}T} \right)}{\sqrt{\eta^{2} + \delta^{2}} - \delta\ \tanh\left( {\sqrt{\eta^{2} + \delta^{2}}T} \right)}$$A grid-search procedure was implemented in an in-house written python program to extract η and δ, where δ is an empirical fit constant. The product of methyl-axis order parameter and overall correlation time constant, $S_{axis}^{2}\tau_{c}$, can be calculated from η using the following relationship, which contains only known physical constants, according to Equation 1 of [@bib65]:$$\eta \approx 0.9\left( \frac{\mu_{0}}{4\pi} \right)\left\lbrack {P_{2}\left( {\cos\text{Θ}_{axis,HH}} \right)} \right\rbrack^{2}\frac{S_{axis}^{2}\gamma_{H}^{4}\hslash^{2}\tau_{c}}{r_{HH}^{6}}$$The physical constants are γ~H~ = 2.67522.10^8^ s^-1^.T^-1^, r~HH~ = 1.813 Å, θ~*axis,HH*~ = 90 degrees, μ~0~ = 4π.10^−7^ H.m^-1^ and P~2~ denotes the second-order Legendre polynomial.

Error margins of the fitted parameters were obtained using a standard Monte Carlo procedure. Hereby, 1000 synthetic datasets were generated, by adding random noise (within the experimentally determined noise levels) onto the data points that were back predicted from the best-fit parameters. These 1000 datasets were fitted analogously to the experimental data, to extract the standard deviation over these fitted parameters. The raw data and analysis scripts have been deposited in the Mendeley data repository (see [Key Resources Table](#sec4.1){ref-type="sec"}).

### CPMG experiments {#sec4.5.4}

CPMG profiles, R~2eff~ as a function of ν~CPMG~, were fitted with a numerical approach, using the program ChemEx (version 0.6.0, available at <https://github.com/gbouvignies/chemex/releases>), in order to obtain a global exchange rate constant, k~ex~, and site-specific chemical-shift differences \|Δω\|. The two-state exchange model was used as an approximation, and the populations of the two exchanging states were set to 50%. The CPMG RD profiles of ALV TIM in its apo state and bound to Ggc1 and Aac3 have been deposited in the Mendeley data repository.

### *In vitro* import experiments {#sec4.5.5}

For quantification of *in vitro* imports experiments ^35^S-labeled proteins or complexes were quantified by autoradiography with Multi Gauge (Fujifilm, Version 3.2). Experiments were performed in triplicate (n = 3) and the error bars indicate the standard error of the mean (SEM). Overlapping error bars were slightly shifted on the x axis for enhanced visibility.

Data and Software Availability {#sec4.6}
------------------------------

NMR resonance assignments have been deposited in the BioMagResBank. The accession number for the resonance assignment is BioMagResBank: 27052. The accession number for SAXS data are SASBDB: SASDEF2 (TIM910) and SASBDB: SASDEG2 (TIM910/Ggc1). CPMG relaxation dispersion data have been deposited in Mendeley data. Accession numbers can be found in the [Key Resources Table](#sec4.1){ref-type="sec"}.
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